This is the README file for the Hello-world project.

Author email: alice@naver.com

Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
Adolescent birth rate (per 1000 women aged 15-19 years)
Contraceptive prevalence (%)
Unmet need for family planning (%)
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Median availability of selected generic medicines (%) - Public
Median consumer price ratio of selected generic medicines - Public
Antiretroviral therapy coverage among people with advanced HIV infection (%)
Children aged <5 years sleeping under insecticide-treated nets (%)
Children aged <5 years with fever who received treatment with any antimalarial (%)
Prevalence of condom use by adults during higher-risk sex (15-49) (%)
Deaths due to malaria (per 100 000 population)
Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
Deaths due to tuberculosis among HIV-positive people (per 100 000 population)
Prevalence of HIV among adults aged >=15 years (per 100 000 population)
Incidence of tuberculosis (per 100 000 population per year)
Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%)
Tuberculosis detection rate under DOTS (%)
Prevalence of tuberculosis (per 100 000 population)
Tuberculosis treatment success under DOTS (%)
Births attended by skilled health personnel (%)
Maternal mortality ratio (per 100 000 live births)
Children aged <5 years stunted (%)
Population below minimum level of dietary energy consumption
nMx - age-specific death rate between ages x and x+n
nqx - probability of dying between ages x and x+n
lx - number of people left alive at age x
ndx - number of people dying between ages x and x+n
nLx - person-years lived between ages x and x+n
Tx - person-years lived above age x
ex - expectation of life at age x
Number of deaths
GBD - population
GBD - crude death rate
Cholera - number of reported cases
Diphtheria - number of reported cases
Japanese encephalitis - number of reported cases
Pertussis - number of reported cases
Number of new leprosy cases
Total tetanus - number of reported cases
Meningitis - number of reported cases
Malaria - number of reported confirmed cases
Poliomyelitis - number of reported cases
Yellow fever - number of reported cases
H5N1 influenza - number of reported cases
Plague - number of reported cases
Mumps - number of reported cases
Number of reported cases of tuberculosis (DOTS)
Congenital Rubella Syndrome - number of reported cases
Neonatal tetanus - number of reported cases
Total rubella - number of reported cases
Mortality - deaths (country)
Mortality - population (country)
Mortality - crude death rate per 100 000 population
Measles - number of reported cases
Mortality - live births (country)
Life expectancy at birth (years)
Healthy life expectancy (HALE) at birth (years)
Neonatal mortality rate (per 1000 live births)
Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
Low-birth-weight newborns (%)
Infants exclusively breastfed for the first six months of life (%)
GBD - Disability-adjusted life years (DALYS)
GBD - Years of life lost (YLL)
GBD - Years lost due to disability (YLD)
Children aged <5 years underweight (%)
Prevalence of current tobacco use among adolescents (13-15 years) (%)
Children aged <5 years overweight (%)
Adults aged &#8805; 20 years who are obese (%)
Alcohol consumption among adults aged &#8805; 15 years (litres of pure alcohol per person per year)
Prevalence of smoking any tobacco product among adults (&#8805;15 years) (%)
Literacy rate among adults aged >= 15 years (%)
Population (in thousands) total
Net primary school enrolment ratio (%)
Population median age (years)
Population proportion under 15 (%)
Population living on <$1 (PPP int. $) a day (%)
Civil registration coverage of births (%)
Population proportion over 60 (%)
Gross national income per capita (PPP int. $)
Civil registration coverage of causes of deaths (%)
Total fertility rate (per woman)
Population living in urban areas (%)
Annual population growth rate (%)
Antiretroviral therapy coverage among HIV-infected pregnant women for PMTCT (%)
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
Median availability of selected generic medicines (%) - Private
Hospital beds (per 10 000 population)
Private prepaid plans as a percentage of private expenditure on health
Per capita government expenditure on health at average exchange rate (US$)
Per capita total expenditure on health (PPP int. $)
Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%)
Children aged <5 years with diarrhoea receiving ORT (%)
Per capita government expenditure on health (PPP int. $)
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
Antenatal care coverage - at least one visit (%)
General government expenditure on health as a percentage of total government expenditure
Births by caesarean section (%)
Median consumer price ratio of selected generic medicines - Private
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
External resources for health as a percentage of total expenditure on health
Population using improved drinking-water sources (%)
Number of dentistry personnel
Children aged 6-59 months who received vitamin A supplementation (%)
Physicians density (per 10 000 population)
Distribution of years of life lost by major cause group
Number of nursing and midwifery personnel
Neonates protected at birth against neonatal tetanus (PAB) (%)
Hib (Hib3) immunization coverage among 1-year-olds (%)
Age-standardized NCD mortality rate (per 100 000 population)
Social security expenditure on health as a percentage of general government expenditure on health
Number of physicians
Deaths due to HIV/AIDS (per 100 000 population)
Out-of-pocket expenditure as a percentage of private expenditure on health
Number of community health workers
Total expenditure on health as a percentage of gross domestic product
Dentistry personnel density (per 10 000 population)
Private expenditure on health as a percentage of total expenditure on health
Nursing and midwifery personnel density (per 10 000 population)
General government expenditure on health as a percentage of total expenditure on health
Community health workers density (per 10 000 population)
Deaths due to malaria (per 100 000 population)
Antenatal care coverage - at least four visits (%)
Distribution of causes of death among children aged <5 years (%)
Per capita total expenditure on health at average exchange rate (US$)
Number of other health service providers
Population using improved sanitation facilities (%)
Other health service providers density (per 10 000 population)
Age-standardized mortality rate by cause (per 100 000 population) - Cancer
Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular
Age-standardized mortality rate by cause (per 100 000 population) - Injuries
Age-standardized mortality rate by cause (per 100 000 population) - Noncommunicable
Distribution of causes of death among children aged <5 years (%) - Malaria
Distribution of causes of death among children aged <5 years (%) - Pneumonia
Distribution of causes of death among children aged <5 years (%) - Injuries
Distribution of causes of death among children aged <5 years (%) - Diarrhoea
Distribution of causes of death among children aged <5 years (%) - Measles
Distribution of causes of death among children aged <5 years (%) - Causes arising in the perinatal period
Distribution of causes of death among children aged <5 years (%) - HIV/AIDS
Distribution of causes of death among children aged <5 years (%) - Other diseases
Distribution of years of life lost by broader causes (%) - Communicable
Distribution of years of life lost by broader causes (%) - Noncommunicable
Distribution of years of life lost by broader causes (%) - Injuries
Access to improved drinking water sources
Access to improved sanitation
Donor commitments (Million, constant 2009 US$)
Commitments to recipient countries (Million, constant 2009 US$)
Donor disbursements (Million, constant 2009 US$)
Disbursements to recipient countries (Million, constant 2009 US$)
Prevalence (in thousands)
Incidence (in thousands)
Death rates (per 100,000)
DALY rates (per 100,000)
Age-standardized DALYs (per 100,000)
Monitor
Protect from tobacco smoke
Offer help to quit tobacco use
Warn about the dangers of tobacco
Enforce bans on tobacco advertising
Raise taxes on tobacco
Prevalence of smoking any tobacco product among persons aged >= 15 years
Daily smoking of any tobacco product (age-standardized rate)
Current smoking of cigarettes (age-standardized rate)
Daily smoking of cigarettes (age-standardized rate)
Health-care facilities (national legislation)
Education facilities except universities (national legislation)
Universities (national legislation)
Government facilities (national legislation)
Indoor offices (national legislation)
Restaurants (national legislation)
Pubs and bars (national legislation)
Public transport (national legislation)
All other indoor public places (national legislation)
Number of places smoke-free (national legislation)
Compliance with regulations on smoke-free environments (national legislation)
Subnational smoke-free legislation authority exists
Comprehensive bans in place subnationally
Fines for violations
Fines on the establishment
Fines on the patron
Dedicated funds for enforcement
Citizen complaints and investigations
Number of reported cases of cholera
Number of reported deaths from cholera
Cholera case fatality rate
Total microscopy examined
Total microscopy positive
Suspected malaria cases
Malaria outpatient cases
Number of reported presumed and confirmed malaria cases
Cases at community level (presumed and confirmed)
Imported cases
All-cause outpatient cases
All-cause inpatient cases
All-cause inpatient deaths
Malaria inpatient cases
Malaria attributed deaths
Total RDT examined
Total RDT positive
Number of P. falciparum
Number of P. vivax
Number of mixed infections
RDT Positive cases at community level
Microscopy slides/RDTs examined
Microscopy slides/RDTs positive
ANC first attendance
IPT 1st dose
IPT 2nd dose
Total number of conventional Insecticide Treated Nets (ITNs) + LLINS sold or delivered
Total number of Long Lasting Insecticide Treated Nets (LLINs) sold or delivered
Number of conventional insecticide-treated nets (ITNs) sold or delivered
Number of households sprayed at least once
Number of households targeted for spraying
Number people targeted for protection by IRS
Number of people protected by IRS
Number of ACT only treatment doses received (public facilities and community)
Total number of ACT treatment courses distributed
Total number of 1st line treatment course distributed
Government health budget (USD)
Government budget for malaria (USD)
Contributions from the Global Fund (USD)
Contributions from the Wolrdbank (USD)
European Union (USD)
Gov. expenditure on malaria (USD)
Household Net Possession - Percentage with more than one (Any type of mosquito net )
Household Net Possession - Average number of nets per household (Any type of mosquito net )
Household Net Possession - Percentage with at least one (Ever treated mosquito net )
Household Net Possession - Percentage with more than one (Ever treated mosquito net )
Household Net Possession - Average number of ever treated nets per household (Ever treated mosquito net )
Household Net Possession - Percentage with more than one (Insecticide treated mosquito nets (ITNs) )
Household Net Possession - Average number of ITNs per household (Insecticide treated mosquito nets (ITNs) )
IPT and Anti-malarial Treatment - Percentage who took 2+ doses SP/Fansidar
Children with fever - Percentage of children who took drug: Combination with artemisinin
Children with fever - Percentage of children who took drug the same or next day: SP/ Fansidar
Children with fever - Percentage of children who took drug the same or next day: Chloroquine
Children with fever - Percentage of children who took drug the same or next day: Combination with artemisinin
Use of mosquito nets - Percentage of all women age 15-49 who Slept under any net last night
Use of mosquito nets - Percentage of all women age 15-49 who Slept under an ever treated net last night
Use of mosquito nets - Percentage of all women age 15-49 who Slept under an ITN last night
Treatment success rate (new smear-positive cases)
Mortality of TB cases (all forms, excluding HIV) per 100 000 population
Number of deaths from TB (all forms, excluding HIV)
Current smoking of any tobacco product (crude rate)
Daily smoking of any tobacco product (crude rate)
Current smoking of cigarettes (crude rate)
Daily smoking of cigarettes (crude rate)
Current users of any smokeless tobacco product (crude rate)
Daily users of any smokeless tobacco product (crude rate)
Ever users of any smokeless tobacco product (crude rate)
Prevalence of current tobacco use among adolescents aged 13-15 years
Current smokers of cigarettes (youth rate)
Exposure to smoke at home
Exposure to smoke outside home
Jurisdiction name
Number of people covered by subnational legislation
Proportion of national population covered by subnational legislation
Number of places smoke-free (subnational legislation)
Health-care facilities (subnational legislation)
Education facilities, except universities (subnational legislation)
Universities (subnational legislation)
Government facilities (subnational legislation)
Indoor offices (subnational legislation)
Restaurants (subnational legislation)
Pubs and bars (subnational legislation)
Public transport (subnational legislation)
All other indoor public places (subnational legislation)
Access to a toll-free quit line
Smoking cessation support is available in hospitals
Smoking cessation support is available in health clinics or other primary care facilities
Smoking cessation support is available in offices of health professionals
Smoking cessation support is available in the community
Smoking cessation support is available in other settings
Nicotine replacement therapy - legally sold
Nicotine replacement therapy - place available
Bupropion - legally sold
Bupropion - place available
Varenicline - legally sold
Varenicline - place available
Ban on deceitful terms on cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
Specific health warnings are mandated for cigarette packaging
Number of health warnings approved by the law for cigarette packaging
Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for cigarette packaging
Health warnings on cigarette packaging must be rotated
Health warnings on cigarette packaging must be written in the principal language(s) of the country
Health warnings on cigarette packaging must include a photograph or graphic
Ban on deceitful terms on other smoked tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
Specific health warnings are mandated for other smoked tobacco packaging
Number of health warnings approved by the law for other smoked tobacco packaging
Health warnings on other smoked tobacco packaging must be rotated
Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging
Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
Health warnings on other smoked tobacco packaging must include a photograph or graphic
Ban on deceitful terms on smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
Specific health warnings are mandated for smokeless tobacco packaging
Number of health warnings approved by the law for smokeless tobacco packaging
Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be rotated
Most sold brand of bidis - price in US$ at official exchange rates
Cheapest brand of bidis - currency reported
Cheapest brand of bidis - price in currency reported
Cheapest brand of bidis - price in US$ at official exchange rates
Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
Health warnings on smokeless tobacco packaging must include a photograph or graphic
Billboard and outdoor advertising
International magazines and newspapers
International television and radio
Internet
Local magazines and newspapers
National television and radio
Point of sale
Subnational bans on tobacco advertising, promotion and sponsorship
Compliance with bans on direct advertising
Appearance of tobacco products in TV and/or films
Brand name of non-tobacco products used for tobacco product
Free distribution in mail or through other means
Non-tobacco products identified with tobacco brand names
Promotional discounts
Sponsored events
Compliance with bans on promotion and sponsorship
Most sold brand of cigarettes - currency reported
Most sold brand of cigarettes - price in currency reported
Most sold brand of cigarettes - price in US$ at official exchange rates
Cheapest brand of cigarettes - currency reported
Cheapest brand of cigarettes - price in currency reported
Cheapest brand of cigarettes - price in US$ at official exchange rates
Most sold brand of bidis - currency reported
Most sold brand of bidis - price in currency reported
Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
Most sold brand of cigarettes - taxes as a % of price - import duties
Most sold brand of cigarettes - taxes as a % of price - specific excise
Most sold brand of cigarettes - taxes as a % of price - total tax
Cheapest brand of cigarettes - taxes as a % of price - ad valorem excise
Cheapest brand of cigarettes - taxes as a % of price - import duties
Cheapest brand of cigarettes - taxes as a % of price - specific excise
Cheapest brand of cigarettes - taxes as a % of price - total tax
Most sold brand of bidis - taxes as a % of price - ad valorem excise
Most sold brand of bidis - taxes as a % of price - import duties
Most sold brand of bidis - taxes as a % of price - specific excise
Most sold brand of bidis - taxes as a % of price - total tax
Cheapest brand of bidis - taxes as a % of price - ad valorem excise
Cheapest brand of bidis - taxes as a % of price - import duties
Cheapest brand of bidis - taxes as a % of price - specific excise
Cheapest brand of bidis - taxes as a % of price - total tax
Government objectives on tobacco control exist
National agency for tobacco control exists
Number of full-time equivalent staff in national agency
Annual budget for tobacco control in currency reported
Reported currency
Annual budget for tobacco control in US$ at official exchange rate
Budget year
Income level
Number of registered vehicles
Estimated number of road traffic deaths
Estimated road traffic death rate (per 100 000 population)
Existence of a national drink-driving law
Attribution of road traffic deaths to alcohol (%)
Existence of a national seat-belt law
Applicability of seat-belt law to all occupants
Existence of a national child-restraint law
Existence of national speed limits
Adaptation of national speed limit at a local level
Specification of national speed law by vehicle type
Existence of a national motorcycle helmet law
Applicability of national motorcycle helmet law to all road types
Applicability of national motorcycle helmet law to all engine types
Requirement of motorcycle helmet use to adhere to standard
Motorcycle helmet wearing rate (%)
Existence of a road safety lead agency
Existence of a national road safety strategy
Availability of funding for national road safety strategy
Existence of a national policy on walking and cycling
Existence of a national policy on public transport
Existence of road safety audit for all new roads
Existence of road safety audit for existing roads
Existence of mandatory vehicle insurance
Existence of a formal pre-hospital care system
Definition of drink-driving by BAC
Distribution of road traffic deaths by type of road user (%)
Blood Alcohol Concentration (BAC) limit for drivers
Seat-belt wearing rate (%)
Applicability of national motorcycle helmet law to all occupants
Type of driving tests for new drivers
Existence of a universal access telephone number for pre-hospital care
Maximum speed limits
Government unit for treatment
Government unit for alcohol and drugs: Location
Government unit for alcohol: Location
Government unit for drugs: Location
No government unit
Government unit for mental health/substance use: Location
Gross national income per capita (Atlas method)
Prevalence of HIV among adults aged 15 to 49 (%)
Year of survey of adults
Representativeness of survey of adults
Repeating interval for survey of adults (years)
Year of survey of youth
Representativeness of youth survey
Repeating interval for survey of youth (years)
Most sold brand of cigarettes - taxes as a % of price - value added tax
Most sold brand of cigarettes - taxes as a % of price - other taxes
Smear-positive tuberculosis case-detection rate (%)
Smear-positive tuberculosis treatment-success rate (%)
Population using solid fuels (%)
Age-standardized mortality rate by cause (per 100 000 population) - Communicable
Distribution of causes of death among children aged <5 years (%) - Prematurity
Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis
Distribution of causes of death among children aged <5 years (%) - Congenital anomalies
Number of pharmaceutical personnel
Number of environment and public health workers
Density of pharmaceutical personnel (per 10 000 population)
Density of environment and public health workers (per 10 000 population)
Maternal mortality ratio (per 100 000 live births) - Country reported estimates
Number of reported cases of tuberculosis
Distribution of causes of death among children aged <5 years (%) - Birth asphyxia
Most sold brand of bidis - taxes as a % of price - value added tax
Most sold brand of bidis - taxes as a % of price - other taxes
Children aged <5 years wasted for age (%)
Prevalence of adults aged &#8805; 15 years who are pre-obese (%) (BMI 25.0-29.99)
Prevalence of adults aged &#8805; 15 years who are overweight (%) (BMI ? 25.0)
Prevalence of adults aged &#8805; 15 years who are in normal range (%) (BMI 18.5-24.99)
Prevalence of adults aged &#8805; 15 years who are underweight (%) (BMI <18.5)
Continued breastfeeding at 1 year (%)
Early initiation of breastfeeding (%)
Exclusive breastfeeding under 4 months (%)
Children ever breastfed (%)
Continued breastfeeding at 2 years (%)
Duration of any breastfeeding
Duration of exclusive breastfeeding
Introduction of solid, semi-solid or soft foods and breast milk (%)
Bottle feeding rate 0-11.9 months (%)
Bottle feeding rate 0-23.9 months (%)
Exclusive breastfeeding under 6 months (%)
BCG immunization coverage among 1-year-olds (%)
Polio (Pol3) immunization coverage among 1-year-olds (%)
Alcohol, consumption of pure alcohol by type of beverage (%)
Consumption by type of alcoholic beverage - market share (%)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)
Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol
Alcohol, tourist consumption (in litres of pure alcohol)
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)
Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines
Alcohol, abstainers lifetime (%)
Abstainers (15-19 years), lifetime (%)
Alcohol, abstainers past 12 months (%)
Abstainers (15-19 years), past 12 months (%)
Alcohol, consumers past 12 months (%)
Alcohol, former drinkers (%)
Alcohol, heavy episodic drinking (population) past 30 days (%)
Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
Alcohol, patterns of drinking score
Age-standardized DALYs, alcohol use disorders, per 100,000
Age-standardized DALYs, breast cancer, per 100,000
Age-standardized DALYs, colon and rectum cancers, per 100,000
Age-standardized DALYs, diabetes mellitus, per 100,000
Age-standardized DALYs, drownings, per 100,000
Age-standardized DALYs, falls, per 100,000
Age-standardized DALYs, fires, per 100,000
Age-standardized DALYs, ischaemic heart disease, per 100,000
Age-standardized DALYs, liver cancer, per 100,000
Age-standardized DALYs, liver cirrhosis, per 100,000
Age-standardized DALYs, maternal conditions, per 100,000
Age-standardized DALYs, mouth and oropharynx cancer, per 100,000
Age-standardized DALYs, oesophagus cancer, per 100,000
Age-standardized DALYs, poisoning, per 100,000
Age-standardized DALYs, prematurity and low birth rate, per 100,000
Age-standardized DALYs, road traffic accidents, per 100,000
Age-standardized DALYs, self-inflicted injury, per 100,000
Age-standardized DALYs, other unintentional injuries, per 100,000
Age-standardized DALYs, violence, per 100,000
Age-standardized death rates, alcohol use disorders, per 100,000
Age-standardized death rates, breast cancer, per 100,000
Age-standardized death rates, colon and rectum cancers, per 100,000
Age-standardized death rates, diabetes mellitus, per 100,000
Age-standardized death rates, drownings, per 100,000
Age-standardized death rates, falls, per 100,000
Age-standardized death rates, fires, per 100,000
Age-standardized death rates, ischaemic heart disease, per 100,000
Age-standardized death rates, liver cancer, per 100,000
Age-standardized death rates, liver cirrhosis, per 100,000
Age-standardized death rates, maternal conditions, per 100,000
Age-standardized death rates, mouth and oropharynx cancer, per 100,000
Age-standardized death rates, oesophagus cancer, per 100,000
Age-standardized death rates, poisoning, per 100,000
Age-standardized death rates, prematurity and low birth rate, per 100,000
Age-standardized death rates, road traffic accidents, per 100,000
Age-standardized death rates, self-inflicted injury, per 100,000
Age-standardized death rates, other unintentional injuries, per 100,000
Age-standardized death rates, violence, per 100,000
Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000
Liver cirrhosis, age-standardized death rates (15+), per 100,000 population
Age-standardized death rates (15+ years), poisoning, per 100,000
Road traffic injuries, age-standardized death rates (15+), per 100,000 population
Age-standardized death rates (15+ years), violence, per 100,000
Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
Alcohol use disorders (15+), 12 month prevalence (%) with 95%
Alcoholic psychosis, incidence, per 100,000
Cautions and arrests for drink-driving, per 100,000 population
Hospital discharges, alcohol-related injuries and poisoning, per 100,000
Hospital discharges, alcoholic liver disease, per 100,000
Perceived trend in alcohol-related harm and consequences
Treatment admissions (inpatient), alcohol dependence, per 100,000
Treatment admissions (inpatient), alcoholic psychosis, per 100,000
Alcohol-related road traffic crashes, per 100,000 population
Alcohol-related road traffic crashes (% of all traffic crashes)
Alcohol-related injury mortality, per 1,000
Alcohol-related disease mortality, per 100,000 (15+ years)
Alcoholic excise tax revenue as a per cent of government revenue
Annual revenues from alcohol excise tax in millions US$
Alcohol expenditure as a per cent of total household expenditure
Social costs of alcohol use in millions US$
Estimated number of people (all ages) living with HIV
Number of adults aged 15 and over living with HIV
Number of women aged 15 and over living with HIV
Number of children under 15 living with HIV
HIV prevalence rate among adults (15-49)
Number of deaths due to HIV/AIDS
Testing and counselling facilities, reported number
Testing and counselling facilities, estimated number per 100 000 adult population
Reported number of people receiving antiretroviral therapy
Reported number of people receiving antiretroviral therapy, month and year of report
Reported number of children receiving antiretroviral therapy
Reported number of children receiving antiretroviral therapy, month and year of report
Pregnant women tested for HIV, reported number
Pregnant women tested for HIV, estimated coverage (%)
Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission
Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission, reporting period
Number of people aged 15 years and over who received HIV testing and counselling, reported number
People aged 15 years and over who received HIV testing and counselling, estimated number per 1000 adult population
Number of people aged 15 years and over who received HIV testing and counselling, reporting period
Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods
Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
Estimated number of children needing antiretroviral therapy based on WHO methods
Estimated antiretroviral therapy coverage among children
Adopted written national policy on alcohol
Alcoholic beverage legally defined
Alcohol use is banned
Surrogate alcohol consumption is a problem
National legislation to prevent illegal alcohol
Prevalence of adults aged &#8805; 15 years who are moderately and severely thin (BMI <17.0)
Prevalence of adults aged &#8805; 15 years who are severely thin (BMI <16.0)
Prevalence of adults aged &#8805; 15 years who are mildly thin (BMI 17.0-18.49)
Prevalence of adults aged &#8805; 15 years who are moderately thin (BMI 16.0-16.99)
Percentage of the children under 15 years with blood lead levels above 5ug/dl
Percentage of the children under 15 years with blood lead levels above 10ug/dl
Percentage of the adults (15+ years) with blood lead levels above 5ug/dl
Percentage of the adults (15+ years) with blood lead levels above 10ug/dl
Lead attributable deaths
Lead attributable DALYs ('000)
Lead attributable deaths per 100'000 capita
Lead attributable DALYs per 100'000 capita
Lead attributable DALYs ('000) in children under 5 years
Lead attributable DALYs per 100'000 children under 5 years
Percentage of children under 15 years exposed to second-hand smoke
Percentage of women (15+ years) exposed to second-hand smoke
Percentage of men (15+ years) exposed to second-hand smoke
Second-hand smoke attributable deaths
Second-hand smoke attributable DALYs ('000)
Second-hand smoke attributable deaths per 100'000 capita
Second-hand smoke attributable DALYs per 100'000 capita
Second-hand smoke attributable deaths ('000) in children under 5 years
Second-hand smoke attributable deaths per 100'000 children under 5 years
Second-hand smoke attributable DALYs ('000) in children under 5 years
Second-hand smoke attributable DALYs per 100'000 children under 5 years
SDG 3.9.2 WASH deaths
Water, sanitation and hygiene attributable deaths ('000) in children under 5 years
Water, sanitation and hygiene attributable deaths per 100'000 capita
Water, sanitation and hygiene attributable deaths per 100'000 children under 5 years
Water, sanitation and hygiene attributable DALYs ('000)
Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years
Water, sanitation and hygiene attributable DALYs per 100'000 capita
Water, sanitation and hygiene attributable DALYs per 100'000 children under 5 years
Ambient air pollution attributable deaths
Ambient air pollution (Annual PM10 [ug/m3])
Percentage of the total population living in cities > 100'000 inhabitants
Ambient air pollution attributable deaths in children under 5 years
Ambient air pollution attributable death rate (per 100 000 population)
Ambient air pollution attributable deaths per 100'000 children under 5 years
Ambient air pollution attributable DALYs
Ambient air pollution attributable DALYs in children under 5 years
Ambient air pollution attributable DALYs (per 100 000 population)
Ambient air pollution attributable DALYs per 100'000 children under 5 years
Household air pollution attributable deaths
Household air pollution attributable deaths in children under 5 years
Household air pollution attributable deaths per 100'000 capita
Household air pollution attributable deaths per 100'000 children under 5 years
Household air pollution attributable DALYs
Household air pollution attributable DALYs in children under 5 years
Household air pollution attributable DALYs (per 100 000 population)
Household air pollution attributable DALYs per 100'000 children under 5 years
Population using electricity as main cooking fuel (%)
Tuberculosis treatment coverage
Number of suspected meningitis deaths reported
Number of suspected meningitis cases reported
Number of deaths due to tuberculosis, excluding HIV
Number of prevalent tuberculosis cases
Number of incident tuberculosis cases
Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
Number of incident tuberculosis cases, (HIV-positive cases)
Population using LPG as main cooking fuel (%)
Population using natural gas as main cooking fuel (%)
Population using biogas as main cooking fuel (%)
Population using kerosene as main cooking fuel (%)
Population using clean fuels and technologies (sum of)(%)
Population using coal as main cooking fuel (%)
Population using charcoal as main cooking fuel (%)
Population using wood as main cooking fuel (%)
Population using dung as main cooking fuel (%)
Population using crop waste as main cooking fuel (%)
Population using solid fuels (sum of) (%)
Population using others (non listed items) as main cooking fuel (%)
Population not cooking (%)
Missing information on cooking fuels (%)
Total survey respondents
Tuberculosis - new and relapse cases
Case detection rate for all forms of tuberculosis
Advertising restrictions on national television
Advertising restrictions on cable television
Advertising restrictions on national radio
Advertising restrictions on local radio
Advertising restrictions in print media
Advertising restrictions at cinemas
Advertising restrictions on billboards
Advertising restrictions at point-of-sale
Advertising restrictions on the internet
Restrictions on product placement on national television
Restrictions on product placement on cable television
Age limits on-premise service
Minimum legal drinking age
Legal blood alcohol concentration (BAC) limits
Random breath testing (RBT) use
Mandatory driver education for habitual offenders
Prices for alcoholic beverages (average, US$)
Trend in real price of alcoholic beverages relative to CPI over the past five years
Off-premise sales restrictions on days
Off-premise sales restrictions on hours
Off-premise sales restrictions on places
Off-premise sales restrictions on outlet density
Off-premise sales restrictions at specific events
Off-premise sales restrictions at petrol stations
On-premise sales restrictions on days
On-premise sales restrictions on hours
On-premise sales restrictions on places
On-premise sales restrictions on outlet density
On-premise sales restrictions at specific events
On-premise sales restrictions to intoxicated persons
Restrictions on sponsorship of sporting events
Restrictions on sponsorship of youth events
Restrictions on sales promotion from producers (parties, events)
Restrictions on sales promotion from retailers (sales below cost)
Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
Government monopoly on production
Government monopoly on retail sales
Licence required for production
Licence required for retail sales
Excise tax as a per cent of the retail price of alcoholic beverages
Excise duty (average) per hectolitre in Euros
Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
Duty paid or excise stamp on alcohol container
Excise tax on alcoholic beverages
Value-added tax (VAT) on alcohol (%)
Value-added tax (VAT), (%)
Restrictions on alcohol use in public places
Health warning labels on alcohol advertising
Health warning labels on alcohol containers
Monitoring
Treatment, services
Interventions, projects, training
Awareness activities
Information, education, prevention
Standard drink measures, in grams per unit
National drinking guidelines
Production in 1000s hectolitres
Imports in 1000s hectolitres
Sales of beer in 1000s hectolitres
Exports of beer (barley) in 1000s hectolitres
Perceived trend in production
Perceived trend in imports
Perceived trend in sales
Perceived trend in exports
Surveys, research
Counselling
Sales of wine in 1000s hectolitres
Sales of spirits in 1000s hectolitres
Exports of wine (grape) in 1000s hectolitres
Exports of spirits in 1000s hectolitres
New cases: Pulmonary, smear-positive
New cases: pulmonary smear-negative
New cases: pulmonary smear unknown/not done
New cases: extrapulmonary
New cases: other
Relapse cases (pre-2013 definition)
Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
Retreatment cases: other
Treatment history unknown
Number of deaths
Deaths per 1 000 live births
Distribution of causes of death among children aged < 5 years (%)
Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
Laboratories providing drug susceptibility testing (DST) (per 5 million population)
Second-line drug susceptibility testing (DST) available
National Reference Laboratory (NRL)
Rifampicin used throughout treatment
% of patients treated with fixed-dose combinations (FDCs)
Paediatric formulations procured for TB patients
Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases
Treatment success rate: previously treated TB cases
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)
Mean BMI (kg/m&#xb2;) (age-standardized estimate)
Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)
Climate change attributable deaths
Climate change attributable DALYs ('000)
Climate change attributable deaths per 100'000 capita
Climate change attributable DALYs per 100'000 capita
Climate change attributable deaths ('000) in children under 5 years
Climate change attributable deaths per 100'000 children under 5 years
Climate change attributable DALYs ('000) in children under 5 years
Climate change attributable DALYs per 100'000 children under 5 years
Occupational risk factors attributable deaths
Occupational risk factors attributable DALYs ('000)
Occupational risk factors attributable deaths per 100'000 capita
Occupational risk factors attributable DALYs per 100'000 capita
Deaths attributable to the environment
Age-standardized deaths attributable to the environment (per 100 000 population)
Disability-adjusted life years (DALYs) attributable to the environment
Age-standardized DALYs attributable to the environment (per 100 000 population)
Deaths attributable to the environment (%)
Disability-adjusted life years (DALYs) attributable to the environment (%)
Total environment attributable deaths ('000) in children under 5 years
Total environment attributable deaths per 100'000 children under 5 years
Total environment attributable DALYs ('000) in children under 5 years
Total environment attributable DALYs per 100'000 children under 5 years
Deaths attributable to the environment in children under 5 years (%)
DALYs attributable to the environment in children under 5 years (%)
UV radiation
UV radiation attributable deaths
UV radiation attributable DALYs ('000)
UV radiation attributable deaths per 100'000 capita
UV radiation attributable DALYs per 100'000 capita
Existence of Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs
Existence of operational policy/strategy/action plan for cardiovascular diseases
Existence of operational policy/strategy/action plan for cancer
Existence of operational policy/strategy/action plan for diabetes
Existence of operational policy/strategy/action plan for chronic respiratory diseases
Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
Existence of operational policy/strategy/action plan to reduce physical inactivity
Existence of operational policy/strategy/action plan to decrease tobacco use
Existence and scope of cancer registry
Existence of risk factor surveillance for selected risk factors (harmful alcohol use, diet, physical inactivity, and tobacco use)
Availability and stage of implementation of guidelines/protocols/standards for the management of diabetes
Availability and stage of implementation of guidelines/protocols/standards for the management of raised blood pressure / hypertension
General availability of cervical cytology at the primary health care level
General availability of acetic acid visualization at the primary health care level
General availability of colon cancer screening at the primary health care level
General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level
General availability of electrocardiogram at the primary health care level
General availability of total cholesterol measurement at the primary health care level
General availability of peak flow measurement spirometry at the primary health care level
General availability of insulin in the public health sector
General availability of aspirin (100 mg) in the public health sector
General availability of metformin in the public health sector
General availability of glibenclamide in the public health sector
General availability of thiazide diuretics in the public health sector
General availability of ACE inhibitors in the public health sector
General availability of CC blockers in the public health sector
General availability of beta blockers in the public health sector
General availability of tamoxifen in the public health sector
General availability of statins in the public health sector
General availability of oral morphine in the public health sector
General availability of nicotine replacement therapy in the public health sector
General availability of salbutamol in the public health sector
General availability of prednisolone tabs in the public health sector
General availability of steroid inhalers in the public health sector
General availability of hydrocortisone injections in the public health sector
General availability of ipratropium bromide in the public health sector
General availability of retinal photocoagulation in the public health system
General availability of renal replacement therapy (by dialysis or transplantation) in the public health system
General availability of radiotherapy in the public health system
General availability of chemotherapy in the public health system
Existence of partnerships/collaborations for implementing key activities related to NCDs
Implementation of fiscal interventions to influence behaviour change
Earmarking of taxes from fiscal interventions to influence behaviour change used to fund health promotion programmes or a health promotion foundation
Occupational airborne particulates attributable deaths
Occupational airborne particulates attributable DALYs ('000)
Occupational airborne particulates attributable deaths per 100'000 capita
Occupational airborne particulates attributable DALYs per 100'000 capita
Occupational carcinogens attributable deaths
Occupational carcinogens attributable DALYs ('000)
Occupational carcinogens attributable deaths per 100'000 capita
Occupational carcinogens attributable DALYs per 100'000 capita
Occupational noise attributable DALYs ('000)
Occupational noise attributable DALYs per 100'000 capita
Occupational ergonomic stressors attributable deaths
Occupational ergonomic stressors attributable DALYs ('000)
Occupational ergonomic stressors attributable deaths per 100'000 capita
Occupational ergonomic stressors attributable DALYs per 100'000 capita
Occupational injuries attributable deaths
Occupational injuries attributable DALYs ('000)
Occupational injuries attributable deaths per 100'000 capita
Occupational injuries attributable DALYs per 100'000 capita
Number of nursing personnel
Number of physicians
Number of midwifery personnel
Number of pharmacists
Number of pharmaceutical technicians/assistants
Number of community health workers
Number of traditional birth attendants
Number of radiographers
Number of other health workers
Number of dental technicians/assistants
Number of health management & support workers
Number of environment and public health workers
Number of laboratory scientists
Number of laboratory technicians/assistants
Number of dentists
Number of traditional medicine practitioners
Number of medical assistants
Number of personal care workers
Number of pharmaceutical personnel
Number of laboratory health workers
Number of dentistry personnel
Number of community and traditional health workers
Number of other health workers
Number of nursing and midwifery personnel
Pharmaceutical personnel density (per 1000 population)
Physicians density (per 1000 population)
Laboratory health workers density (per 1000 population)
Dentistry personnel density (per 1000 population)
Community and traditional health workers density (per 1000 population)
Other health workers density (per 1000 population)
Environmental and public health workers density (per 1000 population)
Health management & support workers density (per 1000 population)
Nursing and midwifery personnel density (per 1000 population)
Raised blood pressure (SBP>=140 OR DBP>=90 OR on medication) (crude estimate)
Raised blood pressure (SBP>=140 OR DBP>=90 OR on medication) (age-standardized estimate)
Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
Mean systolic blood pressure (crude estimate)
Mean systolic blood pressure (age-standardized estimate)
Raised total cholesterol (>= 5.0 mmol/L) (crude estimate)
Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate)
Mean Total Cholesterol (age-standardized estimate)
Mean Total Cholesterol (crude estimate)
Population
Total NCD Deaths (in thousands)
All NCDs, deaths per 100,000 (age-standardized estimate)
Cancers, deaths per 100,000 (age-standardized estimate)
Chronic respiratory diseases, deaths per 100,000 (age-standardized estimate)
Cardiovascular diseases and diabetes, deaths per 100,000 (age-standardized estimate)
Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths (%)
Raised total cholesterol (&#8805; 6.2 mmol/L) (age-standardized estimate)
Raised total cholesterol (&#8805; 6.2 mmol/L) (crude estimate)
Stillbirth rate (per 1000 total births)
Mean fasting blood glucose (mmol/l) (age-standardized estimate)
Mean fasting blood glucose (mmol/l) (crude estimate)
Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate)
Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate)
Radiotherapy units (per 1 000 000 population)
Mean BMI (kg/m&#xb2;) (crude estimate)
Number of new reported cases of Buruli ulcer
Dracunculiasis certification status of countries at the beginning of the year
Annual incidence of dracunculiasis cases
Number of new reported cases of human African trypanosomiasis (T.b. gambiense)
Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense)
Coverage of antenatal care (4 visits)
Coverage of DTP3 immunization
Knowlege about sexual transmission of AIDS
HIV prevalence
Infant mortality per 1 000 live births
Coverage of measles immunization
Prevalence of obesity
Coverage of skilled birth attendance
Prevalence of (moderate or severe) stunting in children
Prevalence of current cigarette smoking
Under-five mortality per 1 000 live births
Population living in urban areas (%)
Population using improved drinking-water sources (%)
Status of elimination of trachoma as a public health problem
Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem
Number of people who received treatment with antibiotics for trachoma
Number of meningitis epidemic districts
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)
Slum population in urban areas (% of total population)
Contraceptive prevalence, among girls aged 15-19 (%)
Unmet need for family planning, among girls aged 15-19 (%)
Births attended by skilled health personnel, among girls aged 15-19 (%)
Antenatal care coverage - at least one visit, among girls aged 15-19 (%)
Handwashing with soap after cleaning child's stool (%)
Handwashing with soap after using the toilet (%)
Point prevalence (%), alcohol use disorders, 15+ years
Point prevalence (%), drug use disorders, 15+ years
Age-standardized death rates, alcohol and drug use disorders, per 100 000
Age-standardized death rates, drug use disorders, per 100 000
Age-standardized DALYs, alcohol and drug use disorders, per 100 000
Age-standardized DALYs, drug use disorders, per 100 000
Psychoactive substance causing entry into treatment
Age-standardized DALYs, cerebrovascular disease, per 100,000
Age-standardized death rates, cerebrovascular disease, per 100,000
Epidemiological data collection system for substance use disorders
Service delivery data collection system for substance use disorders
National survey on substance use among children and adolescents
Data on substance use disorders disseminated in national annual reports
Substance use policy at the national level
Substance use policy at the national level, level of integration
Policy documents on the pharmacological treatment of substance use disorders
Guidelines on the pharmacological treatment of substance use disorders
Legislative provision for treatment and rehabilitation of substance use disorders
Legislative provision for compulsory treatment
Drug courts
Programmes diverting clients from the justice system towards treatment
Confidentiality of health records on substance use disorders protected by law
Government unit for substance use disorder treatment
Budget line for substance use disorder treatment
Financing method for substance use disorder treatment
Treatment services for alcohol use disorders, free of charge
Treatment services for drug use disorders, free of charge
Governement benefits for persons with substance use disorders
Government benefits for alcohol use disorders, subsidy or disability pension
Government benefits for drug use disorders, subsidy or disability pension
Sector for inpatient detoxification of alcohol use disorders
Sector for inpatient treatment of alcohol dependence
Sector for outpatient treatment of alcohol dependence
Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
Sector for residential long-term rehabilitation of alcohol use disorders
Sector for inpatient detoxification of drug use disorders
Sector for inpatient treatment of drug dependence
Sector for outpatient treatment of drug dependence
Sector for substitution maintenance therapy of opioid dependence
Sector for residential long-term rehabilitation of drug use disorders
Treatment system for substance use disorders
Treatment setting for substance use disorders, most common
Ambient air pollution in urban areas (Annual PM<sub>10</sub> [&#956;g/m<sup>3</sup>])
Percent of urban inhabitants living in cities covered by PM measurements
Specialized treatment services for drug use disoders and HIV/AIDS
Specialized treatment services for substance use disorders and TB
Open access services for substance use disorders
Treatment slots for alcohol and drug use disorders, outpatient, per 10 000
Beds for the treatment of substance use disorders, per 100 000
Length of stay for inpatient detoxification, days
Length of stay for inpatient short-term treatment, days
Length of stay for inpatient long-term residential treatment, days
Number of under-five deaths
Number of infant deaths
Number of neonatal deaths
NCD deaths under age 60 (percent of all NCD deaths)
Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
Timeframe of opioid agonist treatment
Methadone used for the treatment of opioid dependence
Methadone used for detoxification or maintenance
Methadone formulation used for the treatment of opiod dependence
Buprenorphine used for the treatment of opioid dependence
Buprenorphine used for detoxification or maintenance
Buprenorphine/naloxone used for the treatment of opioid dependence
Buprenorphine/naloxone used for detoxification or maintenance
Methadone provision in clinical and community-based settings
Buprenorphine provision in clinical and community-based settings
Buprenorphine/naloxone provision in clinical and community-based settings
Supervision requirements for methadone administration
Supervision requirements for buprenorphine administration
Supervision requirements for buprenorphine/naloxone administration
Prescription requirements for methadone
Prescription requirements for buprenorphine
Prescription requirements for buprenorphine/naloxone
Commencement of treatment with opioid agonists
Pharmacotherapy used for the management of alcohol withdrawal
Pharmacotherapy used for the management of benzodiazepine withdrawal
Pharmacotherapy used for the management of cannabis withdrawal
Essential list of medicines
Essential list of medicines, pharmacotherapy for substance use disorders
Anti-tobacco mass media campaigns
National tobacco control programmes
Survey age range
Law mandates that health warnings appear on tobacco packages
Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on cigarette packaging law requires or establishes fines for violations
Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Cigarette packaging and labelling must not use descriptors depicting flavours
Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
The quit line number must appear on cigarette packaging or labelling
Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Law mandates that health warnings appear on smokeless tobacco packages
Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
The quit line number must appear on smokeless tobacco packaging or labelling
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
At least one national mass media campaign ran during the survey period
Campaign was part of a comprehensive tobacco control programme
Campaign was pre-tested
Formative research was conducted
Campaign utilized media planning
Earned media/public relations were used to promote the campaign
Process evaluation was employed to assess implementation
Outcome evaluation was employed to assess effectiveness
Ban on appearance of tobacco brands in TV and/or films (product placement)
Proportion of children aged 6-23 months who receive a minimum acceptable diet
Minimum dietary diversity (%)
Minimum meal frequency (%)
Most sold brand of cigarettes - price in international dollars
Cheapest brand of cigarettes - price in international dollars
Most sold brand of bidis - price in international dollars
Tobacco excises increased over the survey period
Government unit for substance use disorder prevention
Budget line for substance use disorder prevention
Funding method for substance use disorder prevention
Prevention activities for substance use disorders, main focus
Programmes for the prevention of substance use disorders for special populations
Screening and brief interventions for substance use and substance use disorders
Harm reduction programmes for IDUs
Health professionals mostly involved in treatment of substance use disorders
Clinical supervision of health care staff
Standards of care for health professionals
Standards of care for health professionals, maintenance
Standards of care for health professionals, human rights
NGOs for alcohol use disorders
NGOs for drug use disorders
Self-help groups for substance use disorders
Groups and agencies for the prevention of substance use disorders
Mental health policy
Mental health plan
Stand-alone law for mental health
Government expenditures on mental health as a percentage of total government expenditures on health (%)
Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
Psychiatrists working in mental health sector (per 100 000 population)
Nurses working in mental health sector (per 100 000 population)
Social workers working in mental health sector (per 100 000 population)
Psychologists working in mental health sector (per 100 000 population)
Mental health outpatient facilities (per 100 000 population)
Mental health day treatment facilities (per 100 000 population)
Age-standardized suicide rates (per 100 000 population)
Beds for mental health in general hospitals (per 100 000 population)
Community residential facilities (per 100 000 population)
Beds in community residential facilities (per 100 000 population)
Beds in mental hospitals (per 100 000 population)
Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
Mental hospitals (per 100 000 population)
Mental health units in general hospitals (per 100 000 population)
Children aged <5 years with ARI symptoms who took antibiotic treatment (%)
Life expectancy at age 60 (years)
Malaria - number of reported deaths
Estimated number of malaria cases
Estimated number of malaria deaths
Total density per 100 000 population: Health posts
Total density per 100 000 population: Health centres
Total density per 100 000 population: District/rural hospitals
Total density per 100 000 population: Provincial hospitals
Total density per 100 000 population: Specialized hospitals
Availability of national standards or recommended lists of medical devices
Types of lists recommending health technology for high burden diseases
Total density per million population: Magnetic Resonance Imaging
Total density per million population: Computed tomography units
Total density per million population: Positron Emission tomography
Total density per million population: Gamma camera or Nuclear medicine
Total density per million population: Linear Accelerator
Type of nomenclature system
Use of nomenclature system
Health technology (medical device) national policy
Unit in the Ministry of Health responsible for the management of medical devices
Procurement of medical devices carried out at the national level
Availability of national list of approved medical devices for procurement or reimbursement
National guidelines, policies or recommendations on the procurement of medical devices
Availability of technical specifications of medical devices to support procurement or donations
Total density per million population: Telecobalt Unit
Total density per million population: Radiotherapy units
Total density per million females aged from 50 to 69 years old: Mammography units
Postnatal care visit within two days of birth (%)
Central coordinating entity for alcohol policy implementation
Framework of national alcohol policy
Level of adoption of national alcohol policy
Sectors represented in national alcohol policy
Cautions and arrests for public drunkenness, per 100,000 population
Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - All causes
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cancer
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cardiovasular disease and diabetes
Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Chronic respiratory conditions
Crude birth rate (per 1000 population)
Crude death rate (per 1000 population)
Cellular subscribers (per 100 population)
Most recent census (year)
Number of cause-of-death registration years available
Number of national population surveys - child anthropometry
Number of national population surveys - child mortality
Number of national population surveys - maternal mortality
Number of national population surveys - HIV prevalence
Number of national population surveys - adult health
Civil registration coverage of cause-of-death (%)
Ill-defined causes in cause-of-death registration (%)
International Statistical Classification of Diseases and Related Health Problems (ICD)
Testing and counselling facilities, reporting period
Number of under-five deaths from malaria
Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (%)
BCG immunization coverage among one-year-olds (%)
Contraceptive prevalence - modern methods (%)
Contraceptive prevalence - use of modern and traditional methods (%)
DTP3 immunization coverage among one-year-olds (%)
Early initiation of breastfeeding (in the two or three years preceding the survey) (%)
Family planning needs satisfied (%)
Full immunization coverage among 1-year-olds (%)
Children aged <5 years sleeping under insecticide-treated nets (%)
Measles (MCV) immunization coverage among 1-year-olds (%)
Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%)
Children aged <5 years with ARI symptoms taken to facility (%)
Polio immunization coverage among one-year-olds (%)
Births attended by skilled health personnel (in the two or three years preceding the survey) (%)
Children aged <5 years stunted (%)
Children aged <5 years underweight (%)
Children aged 6-59 months who received vitamin A supplementation (%)
Antenatal care coverage - at least one visit (in the three years preceding the survey) (%)
Antenatal care coverage - at least one visit (in the five years preceding the survey) (%)
Antenatal care coverage - at least four visits (in the three years preceding the survey) (%)
Antenatal care coverage - at least four visits (in the five years preceding the survey) (%)
Births by caesarean section (in the three years preceding the survey) (%)
Births by caesarean section (in the five years preceding the survey) (%)
Early initiation of breastfeeding (in the three years preceding the survey) (%)
Early initiation of breastfeeding (in the five years preceding the survey) (%)
Pregnant women sleeping under insecticide-treated nets (%)
Prevalence of obesity in non-pregnant women aged 15 - 49 years, BMI >= 30 (%)
Postnatal care visit within two days of birth (in the three years preceding the survey) (%)
Postnatal care visit within two days of birth (in the five years preceding the survey) (%)
Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%)
Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%)
Births attended by skilled health personnel (in the three years preceding the survey) (%)
Births attended by skilled health personnel (in the five years preceding the survey) (%)
Stunting prevalence in children aged < 3 years (%)
Stunting prevalence in children aged < 5 years (%)
Underweight prevalence in children aged < 3 years (%)
Underweight prevalence in children aged < 5 years (%)
Adolescent fertility rate (births per 1000 women aged 15-19 years)
Total fertility rate (births per woman)
Child mortality rate (probability of dying between age 1 and age 5 per 1000 live births)
Infant mortality rate (deaths per 1000 live births)
Neonatal mortality rate (deaths per 1000 live births)
Postneonatal mortality rate (probability of dying between age 30 days and 11 months per 1000 live births)
Under-five mortality rate (deaths per 1000 live births)
Adopted written national policy on alcohol, year adopted
Adopted written national policy on alcohol, year revised
Age limits off-premise sales
Consumer information on alcohol and health at points of sale
Educational programmes involving target groups in school curriculum
Brief interventions as health promotion/disease prevention
Server training on a regular basis
Data collection on alcohol-related health indicators
System for monitoring alcohol-related harm
National treatment policy for alcohol use disorders
Persons with alcohol use disorders receiving treatment (%)
Designation of alcohol tax revenues to health services
National surveys on drink-driving
Public-funded alcohol research/monitoring programmes
Public funds designated for alcohol research/monitoring programmes, in Euros
Community-based interventions/projects involving stakeholders
Interventions/projects actively involving young people and civil society
Training in screening and brief interventions for alcohol problems
Counselling to children in families with alcohol problems
Counselling to pregnant women with alcohol problems
Prevention/counselling at workplaces for those with alcohol problems
Total Pharmaceutical Expenditure (millions US$)
Total Pharmaceutical Expenditure per capita (US$)rate)
Share of Total Pharmaceutical Expenditure in Total Health Expenditure (%)
Share of Public Pharmaceutical Expenditure in Total Pharmaceutical Expenditure (%)
Public Pharmaceutical Expenditure per capita (US$)
Density of pharmacists (per 10 000 population)
Presence of National Medicines Policy
Presence of National Medicines Policy implementation plan
Right of access to essential medicines
Existence of formal Medicines Regulatory Authority
Website of the formal Medicines Regulatory Authority
Market Authorization for all pharmaceutical products required
Registration Fee pharmaceutical containing New Chemical Entity
Registration Fee generic pharmaceutical product
Inspectors are allowed to inspect premises where pharmaceutical activities are performed
Pharmaceutical manufacturers must comply with Good Manufacturing Practices
Licensing private pharmacies obligatory
National Quality Control Laboratory exists
Legal provisions control promoting and advertising of prescription medicine
Ban on Direct to Consumer Pharmaceutical Advertising
Legal provisions exist requiring authorization for conducting Clinical Trials by the MRA
Annual consumption of Morphine (mg/capita)
National pharmacovigilance centre linked to the MRA exists
Children <5 years receive free medicines
Pregnant women receive free medicines
All medicines included in the EML
Social (health) fund is providing at least partial medicine coverage
System in place to monitor prices of medicines
Duties on imported active pharmaceutical ingredients
Duties on imported finished pharmaceutical products
Value Added Tax is levied on finished pharmaceuticals products
Public sector tender awards are publicly available
Availability of key medicines at the Central Medical Store in percentage (%)
National Essential Medicine List exists
Standard Treatment Guidelines for common illnesses are made by Ministry of Health
National Standard Treatment Guidelines specific to paediatric conditions exist
National Medicines Information Center provides information on medicines
Existence of National strategy to contain antimicrobial resistance
Public sector
Private sector
Substitution of generic equivalents at the point of dispensing in public sector facilities is allowed
Substitution of generic equivalents at the point of dispensing in private sector facilities is allowed
For the pharmaceutical sector
Number of registered pharmaceutical products
Number of reports submitted in the last two year by the pharmacovigilance centre
Market share of domestic manufacturers (%)
Market share of generic pharmaceuticals by value (%)
Basis for NHA estimate
Women accessing antenatal care (ANC) services who were tested for syphilis (%)
Antenatal care attendees who were positive for syphilis (%)
Sex workers with active syphilis (%)
Men who have sex with men (MSM) with active syphilis (%)
Number of new HIV infections
Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
Reported % of seriously injured patients transported by ambulance
Training in medical emergency - available for doctors
Training in medical emergency - available for nurses
Malaria incidence per 100 000 population
Preterm birth rate (per 100 live births)
Age-standardized death rates (per 100 000 population)
Population
Life Expectancy M
Life Expectancy F
Under 5 Mortality
Infant mortality
GDP
Gross domestic product per capita
NCD mortality rate
CVD and Diabetes mortality rate
Cancer mortality rate
TB mortality rate
Malaria mortality rate
HIV mortality rate
THE
THE per capita
Public Health Expenditure
Public Health Expenditure per capita
Public Health Expenditure as a % of Government Expenditure
Public Health Expenditure of a % of THE
OOP as a % of THE
Private Health Expenditure % of THE
OOP as a % of Private Health Expenditure
Premiums for private health plans as a % of private health expenditure
Population covered by private health insurance
Population covered by a public health service orr insurance plan
Total pharmaceutical expenditure
Share of total pharmaceutical expenditure in total health expenditure (%)
Share of total pharmaceutical expenditure in gross domestic product (%)
Total pharmaceutical expenditure per capita
Share of public pharmaceutical expenditures in total pharmaceutical expenditures (US$)
Private TPE
Market share of generic pharmaceuticals by value (%)
Pharmacists
Density of pharmacist (per 10.000)
Presence of National Health Policy
NHP Implementation plan exists
Presence of national medicines policy
Presence of national medicines policy implementation plan
Pharmaceutical policy implementation is regularly monitored
Presence of National Clinical Laboratory Policy
NCLP implementation plan exists
Right of access to essential medicines
Presence of national good governance policy
Official guidelines on medicine donations exist
Policy to manage conflict of interest issues
Formal code of conduct for public officials
Whistle Blowing mechanism
Legal provision for granting patents on: Pharmaceuticals
Legal provision for granting patents on: Laboratory Supplies
Legal provision for granting patents on: Medical Supplies
Legal provision for granting patents on: Medical Equipment
TRIPS legislated through national legislation
Trasitional period eligibility
Compulsory Licensing
Bolar exemption
Parallel importing
Legal provisions related to: Data exclusivity
Legal provisions related to: Patent Extension
Legal provisions for the linkage between patent status and market authorization
Number of licensed pharmaceutical manufacturers
Manufacturing capacity: R&D new API
Manufacturing capacity: Production API
Manufacturing capacity: Production formulations
Manufacturing capacity: Repackaging of finished dose forms
Market share of domestic manufacturers by value (%)
Market share of domestic manufactures by volume (%)
Legal provisions for establishing MRA
Formal medicines regulatory authority exists
MRA part of MoH
MRA semi-autonomous
Medicines regulatory authority has it own website
MRA receives external technical assistance
MRA involved in harmonization / collaboration activities
Assessment of medicines regulatory system conducted in last 5 years
RA uses computerized information management system
Function of MRA: Market Authorization
Function of MRA: Inspection
Function of MRA: Import Control
Function of MRA: Licensing
Function of MRA: Market control
Function of MRA: Quality control
Function of MRA: Advertising
Function of MRA: Clinical trials
Function of MRA: Pharmacovigilance
Funding of MRA: Government
Funding of MRA: Fees for service
Funding of MRA: Other funding
Funding of MRA: Revenues derived from RA kept in RA
Market authorization for all pharmaceutical products is required
Mechnaisms for exceptions / waiver of registration
Mutual recognition
Public transparency of criteria for MA application assessment
WHO prequalification programme information used for product registration
Number of registered pharmaceuticals
List of pharmaceuticals with defined periodicity required to be publicly available
Medicines registration includes INN
Fee required for Marketing Authorization applications
Fee for pharmaceuticals containing new chemical entity
Registration fee generic pharmaceutical product
Legal provisions for the appointment of government pharmaceutical officials
Inspectors are allowed to inspect premises where pharmaceutical activities are performed
Inspection a pre-requisite for licensing of: Public
Inspection a pre-requisite for licensing of: Private
Inspection requirements the same for public and private facilities
Local manufacturers - GMP compliance
Private Wholesalers
Retail distributors
Public pharmacies and stores
Pharmacies and dispensing points of health facilities
Authorization to import medicines required
Sampling of imported products for testing permitted
Importation of medicines through authorized ports of entry
Inspection of pharmaceutical products at authorized ports of entry permitted
Pharmaceutical manufacturers must comply good manufacturing practices
Licensing required for: Manufacturers
Licensing required for: Importers
Licensing required for: Wholesalers
Licensing private pharmacies obligatory
Licensing required for: public pharmacies
Wholesalers and distributors to comply with Good Distribution Practices
Pharmacists to be registered
Good Manufacturing Practices (GMP) published
National Good Distribution Practice requirements published
National Good Pharmacy Practice Guidelines published
List of all licensed pharmaceutical facilities (publication legally required)
Legislation supports Pharmaceutical market regulation
Quality control testing laboratory is available
Quality control laboratory is part of medication regulatory authority
Testing services contracted out by regulatory authority
For quality monitoring in public sector (pharmacy stores and health facilities)
For quality monitoring in private sector (retail outlets)
When there are complaints / problems
For product registration
For public procurement prequalification
For public program products prior to acceptance and/or distribution
Number of quality control samples tested in past two years
Number of samples that failed the testing in two years
Legal provisions control promoting and advertising of prescription medicine
Ban on direct to consumer pharmaceutical advertising
Pre-approval for medicines advertisements and promotional materials required
Guidelines for advertising and promotion of non-prescription medicines
Code of conduct for advertising by MA holders exists and is publicly available
Code of conduct applies to: Both
Voluntary adherence to code
Code contains formal process for complaints and sanctions
Up to date list of complaints and sanctions publicly available
Legal provisions exist requiring authorization for conducting clinical trials by the medical regulatory authority
Clinical Trials require ethics committee/institutional review board approval
Registration of clinical trials in international/national/regional registry
Single convention on narcotic drugs, 1961
The 1972 protocol amending the single convention on narcotic drugs, 1961
Convention on psychotropic substances, 1971
United nations convention against the illicit traffic in narcotic drugs and psychotropic substances, 1988
Laws for the control of narcotic and psychotropic substances, and precursors exist
Annual morphine consumption (mg/capita)
PV activities legally established within MRA mandate
MA holders required to continuously monitor safety of products and report to MRA
Legal provisions for monitoring of ADR exist
National pharmacovigilance center linked to the medicines regulatory authority
Number of reports submitted in the last two years by the national pharmacovigilance center
NPC publishes ADR bulletin
No. of ADRs on database
Number of reports of adverse drug reactions submitted in the last two years by the national pharmacovigilance center
No. of ADRs submitted to Uppsala database
Patients who cannot afford them received free medicines
Children under 5 receive free medicines
Pregnant women receive free medicines
Elderly received free medicines
All essential medicines are free
Free medicines for any non communicable diseases
Free medicines for Malaria
Free medicines for TB
Free medicines for STD
Free medicines for HIV
Free vaccines for EPI
National or social health insurance providing at least partial medicines coverage
Providing medicines that are on the Essential Medicines List for inpatients
Providing medicines that are on the Essential Medicines List for outpatients
Private health insurance schemes provide medicines coverage
Private health insurance provides coverage for medicines which are on the EML
Co-payments/ fee requirements for consultations
Co-payments/ fee requirements for medicines
Medicine pricing regulations
Pricing provisions aimed at: Manufacturers
Pricing provisions aimed at: Wholesalers
Pricing provisions aimed at: Retailers
Duties on active pharmaceutical ingredients
Duties on finished pharmaceutical products
Value added taxes on pharmaceutical products
Duty rate on active pharmaceutical ingredients
Duty rate on finished pharmaceutical products
Value added taxes rate
Revenues from fees used to pay salaries of health workers
Public sector procurement is decentralized
Public sector procurement is decentralized and centralized
Public sector procurement is the reponsibility of procurement agency that is part of MOH
Public sector procurement is the reponsibility of procurement agency that is semi autonomous
Public sector procurement is the reponsibility of procurement agency that is autonomous
A government procurement agency procures all public goods
Public sector requests for tender documents are publicly available
Public sector awards are publicly available
Procurement is based on prequalification of suppliers
The government supply system department has a central medical store
There are national guidelines on Good Distribution Practices
There is a licensing authority that issues GDP licenses
The licensing authority accredits public distribution facilities
A list of GDP certified warehouses in the public sector exists
A list of GDP certified distributors in the public sector exists
Availability of key medicines at the central medical store
Legal provisions exist for licensing wholesales in private sector
Legal provisions exist for licensing distributors in private sector
A list of GDP certified wholsesalers in the private sector exists
A list of GDP certified distributors in the private sector exists
Core medical training includes: concept of EML
Core medical training includes: Use for STGS
Core medical training includes: Pharmacovigilance
Core medical training includes: Problem based pharmacotherapy
Mandatory continuing education that includes pharmaceutical issues is required for doctors
Mandatory continuing education that includes pharmaceutical issues is required for nurses
Mandatory continuing education that includes pharmaceutical issues is required for paramedical staff
Public sector generic prescribing is obligatory
Private sector generic prescribing is obligatory
Core pharmacist training includes: EML
Core pharmacist training includes: Use of STG
Core pharmacist training includes: drug information
Core pharmacist training includes: clinical pharmacology
Core pharmacist training includes: medicines supply management
Generic substitution permitted in public sector
Generic substitution permitted in private sector
Antibiotics are sometimes sold OTC without prescription
Injectables are sometimes sold OTC without prescription
National medicines information center exists
Public education campaigns on rational medicine use topics have been conducted in previous two years
A survey on rational medicine use has been conducted in the previous two years
A national committee exists to monitor and promote rational use of medicines
National strategy to contain antimicrobial resistance exists
Existence of a funded national intersectoral taskforce to coordinate the promotion of appropriate use of antimicrobials
A national reference lab has responsibility for coordinating epidemiological surveillance of AMR
Legal provisions exist to govern the licensing and prescribing practices of prescriber
Legal provisions exist to restrict dispensing by prescribers
Prescribers in the private sector dispense medicine
Regulations require hospitals to organize/develop DTCs
More than half of referral hospital have a DTC
More than half of general hospitals have a DTC
More than half of regions/provinces have a DTC
Average number of medicines prescribed per patient contact in public health facilities
Percentage of medicines in outpatient public health care facilities that are prescribed by INN name
Percentage of patients in outpatient public health care facilities receiving antibiotics
Percentage of patients in outpatient public health care facilities receiving injections
Percentage of medicines adequately labelled in public health facilities
Diarrhoea in children treated with ORS
Nurses sometimes prescribe prescription-only medicines
Pharmacists sometimes prescribe prescription-only medicines
Paramedics sometimes prescribe prescription-only medicines
Personnel with less than one month training sometimes prescribe prescription-only medicines
Legal provisions exist to govern dispensing practices of pharmaceutical personnel
Number of medicines on essential medicines list
Written process for selecting medicines on the EML
Written process is publicly available
Mechanism to align EML and STG
Standard treatment guidelines for common illnesses produced by the ministry of health
STG specific to primary care exists
STG specific to secondary care exists
National standard treatment guidelines for children
% of public health facilities with copy EML (mean)
% of public health facilities with copy STG (mean)
EML includes formulations specific for children
There are explicitly documented criteria for the selection of medicines on the EML
There is a formal committee for the selection of products on the EML
Conflict of interest declarations are required from members of national EML committee
National medicines formulary exists
% of medicines prescribed in outpatient public health care facilities that are on the EML
Mandatory continuing education that includes rational use of medicines is required for pharmacists
Number of deaths
Deaths per 100 000 population
Poverty headcount ratio at $1.25 a day (PPP) (% of population)
Human development index rank
Gender inequality index rank
Share of public pharmaceutical expenditures in total pharmaceutical expenditures (%)
Generic
AMR strategy has been updated in 2010 or later
Essential medicines list exists
Overweight prevalence among children under 5 years of age (%)
Overweight numbers among children under 5 years of age (millions)
Severe wasted prevalence among children under 5 years of age (%)
Severe wasted numbers among children under 5 years of age (millions)
Stunting prevalence among children under 5 years of age (%)
Stunting numbers among children under 5 years of age (millions)
Underweight prevalence among children under 5 years of age (%)
Underweight numbers among children under 5 years of age (millions)
Wasted prevalence among children under 5 years of age (%)
Wasted numbers among children under 5 years of age (millions)
Intimate partner violence prevalence among ever partnered women (%)
Non-partner sexual violence prevalence (%)
Monitor
Protect from tobacco smoke
Offer help to quit tobacco use
Warn about the dangers of tobacco
Anti-tobacco mass media campaigns
Enforce bans on tobacco advertising
Raise taxes on tobacco
Estimate of current tobacco use prevalence (%)
Estimate of daily tobacco use prevalence (%)
Estimate of current cigarette smoking prevalence (%)
Estimate of daily cigarette smoking prevalence (%)
Year of latest adult prevalence survey
Name of survey of adults
Representativeness of survey of adults
Adult survey age range
Adult indicator 1 definition
Adult indicator 1 rate
Adult indicator 2 definition
Adult indicator 2 rate
Year of survey of adults - smokeless
Name of survey of adults - smokeless
Representativeness of survey of adults - smokeless
Adult survey age range - smokeless
Adult smokeless tobacco use indicator definition
Adult smokeless tobacco use indicator rate
Year of survey of youth
Name of survey of youth
Representativeness of youth survey
Youth survey age range
Youth indicator 1 definition
Youth indicator 1 rate
Youth indicator 2 definition
Youth indicator 2 rate
Year of survey of youth - smokeless
Name of survey of youth - smokeless
Representativeness of survey of youth - smokeless
Youth survey age range - smokeless
Youth smokeless tobacco use indicator definition
Youth smokeless tobacco use indicator rate
Smoke-free health-care facilities (national legislation)
Smoke-free education facilities except universities (national legislation)
Smoke-free universities (national legislation)
Smoke-free government facilities (national legislation)
Smoke-free indoor offices (national legislation)
Smoke-free restaurants (national legislation)
Smoke-free pubs, bars and cafés (national legislation)
Smoke-free public transport (national legislation)
Smoke-free other indoor public places (national legislation)
Compliance with regulations on smoke-free environments (national legislation)
Number of places smoke-free (national legislation)
Fines for violations of smoke-free laws
Fines on the establishment for violations of smoke-free laws
Fines on the patrons of establishments for violations of smoke-free laws
Dedicated funds for enforcement of smoke-free laws
Citizen complaints and investigations of violations of smoke-free laws
Subnational smoke-free legislation authority exists
Comprehensive bans in place subnationally
Access to a toll-free quit line
Smoking cessation support is available in hospitals
Smoking cessation support is cost-covered in hospitals
Treatment for tobacco dependence available in health clinics or other primary care facilities
Smoking cessation support is available in offices of health professionals
Smoking cessation support is cost-covered in offices of health professionals
Smoking cessation support is available in the community
Smoking cessation support is cost-covered in the community
Smoking cessation support is available in other settings
Smoking cessation support is cost-covered in other settings
Nicotine replacement therapy - legally sold
Nicotine replacement therapy - place available
Nicotine replacement therapy - cost covered
Nicotine replacement therapy - on the Essential Medicines List
Bupropion - legally sold
Bupropion - place available
Bupropion - cost covered
Varenicline - legally sold
Varenicline - place available
Varenicline - cost covered
Law mandates that health warnings appear on cigarette packages
Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
Specific health warnings are mandated for cigarette packaging
Number of health warnings approved by the law for cigarette packaging
Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for cigarette packaging
Health warnings on cigarette packaging must be rotated
Health warnings on cigarette packaging must be written in the principal language(s) of the country
Health warnings on cigarette packaging must include a photograph or graphic
Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on cigarette packaging law requires or establishes fines for violations
Ban on deceitful terms on cigarette packaging
Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Cigarette packaging and labelling must not use descriptors depicting flavours
Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Cigarette packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of cigarette packaging
Display of expiry dates is prevented on cigarette packaging
The quit line number must appear on cigarette packaging or labelling
Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
Ban on sale of smokeless tobacco products
Law mandates that health warnings appear on smokeless tobacco packages
Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
Specific health warnings are mandated for smokeless tobacco packaging
Number of health warnings approved by the law for smokeless tobacco packaging
Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be rotated
Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
Health warnings on smokeless tobacco packaging must include a photograph or graphic
Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
Ban on deceitful terms on smokeless tobacco packaging
Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Smokeless tobacco packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of smokeless tobacco packaging
Display of expiry dates is prevented on smokeless tobacco packaging
The quit line number must appear on smokeless tobacco packaging or labelling
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
At least one national mass media campaign ran during the survey period
Campaign was part of a comprehensive tobacco control programme
Campaign was pre-tested
Formative research was conducted prior to the campaign
Campaign ran on both national television and radio
Campaign utilized media planning
Earned media/public relations were used to promote the campaign
Process evaluation was employed to assess implementation
Outcome evaluation was employed to assess effectiveness of the campaign
Ban on advertising on national television and radio
Ban on advertising on international television and radio
Ban on advertising in local magazines and newspapers
Ban on advertising in international magazines and newspapers
Ban on billboard and outdoor advertising
Ban on advertising: Point of sale
Ban on advertising on the internet
Compliance with bans on direct advertising
Ban on free distribution in mail or through other means
Ban on promotional discounts
Ban on identifying non-tobacco products with tobacco brand names
Ban on use of brand name of non-tobacco product for tobacco product
Ban on appearance of tobacco brands in TV and/or films (product placement)
Appearance of tobacco products in TV and/or films
Sponsored events
Compliance with bans on promotion and sponsorship
Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities
Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility� activities of the tobacco companies
Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth
Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images
Complete ban on tobacco vending machines
Subnational bans on tobacco advertising, promotion and sponsorship
Most sold brand of cigarettes - currency reported
Most sold brand of cigarettes - price in currency reported
Most sold brand of cigarettes - price in international dollars
Most sold brand of cigarettes - price in US$ at official exchange rates
Cheapest brand of cigarettes - currency reported
Cheapest brand of cigarettes - price in currency reported
Cheapest brand of cigarettes - price in international dollars
Cheapest brand of cigarettes - price in US$ at official exchange rates
Most sold brand of cigarettes - taxes as a % of price - specific excise
Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
Most sold brand of cigarettes - taxes as a % of price - import duties
Most sold brand of cigarettes - taxes as a % of price - value added tax
Most sold brand of cigarettes - taxes as a % of price - other taxes
Most sold brand of cigarettes - taxes as a % of price - total tax
Tobacco excises increased over the survey period
Average - cigarette currency
Average - cigarette price in currency
Average - cigarette price in international dollars
Average - cigarette price in US$ at official exchange rates
Average - taxes as a % of cigarette price - specific excise
Average - taxes as a % of cigarette price - ad valorem excise
Average - taxes as a % of cigarette price - import duties
Average - taxes as a % of cigarette price - value added tax
Average - taxes as a % of cigarette price - other taxes
Average - taxes as a % of cigarette price - total tax
Tobacco tax revenues - tobacco product types included
Tobacco tax revenues - year reported
Tobacco tax revenues - currency reported
Tobacco tax revenues - total excise (specific and ad valorem)
Tobacco tax revenues - valued added tax (VAT) and other sales taxes
Tobacco tax revenues - import duties and all other taxes
Tobacco tax revenues - total revenues
Government objectives on tobacco control exist
National agency for tobacco control exists
Number of full-time equivalent staff in national agency
Annual budget for tobacco control in currency reported
National tobacco control budget - currency reported
Budget year
Budget year
Comprehensive bans in place subnationally
Prevalence of (moderate or severe) underweight in children
Prevalence of (moderate or severe) overweight in children
Households using an improved drinking-water source (%)
Households using a piped drinking-water source (%)
Households using a piped onto premises drinking-water source (%)
Households that have a bednet for sleeping (%)
Women that slept under a bednet last night (%)
Households that use solid fuels for cooking (%)
Proportion of urban residents living in a slum area
Tuberculosis - new and relapse cases
Status of yaws endemicity
Number of cases of yaws reported
Tuberculosis - new and relapse cases
TB patients with known HIV status (%)
Tested TB patients HIV-positive (%)
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Estimated MDR-TB cases among notified pulmonary TB cases
New cases tested for RR-/MDR-TB (%)
Previously treated cases tested for RR-/MDR-TB (%)
Confirmed cases of MDR-TB
Confirmed cases of MDR-TB started treatment for MDR-TB (%)
Treatment success rate for patients treated for MDR-TB (%)
Total number of notified TB cases
Smoking cessation support is available in health clinics or other primary care facilities
Smoking cessation support is cost-covered in health clinics or other primary care facilities
Projection of number of deaths
Projection of deaths per 100 000 population
ICT Development Index (IDI)
ICT Development Index (IDI) rank
Percentage of individuals using the Internet
Disability-adjusted life years (DALYs)
Disability-adjusted life years (DALYs) (per 100 000 population)
Years of healthy life lost due to disability (YLDs)
Years of healthy life lost due to disability (YLDs) (per 100 000 population)
Years of life lost from mortality (YLLs)
Years of life lost from mortality (YLLs) (per 100 000 population)
Mobile-cellular telephone subscriptions per 100 inhabitants
Status of endemicity of cutaneous leishmaniasis
Status of endemicity of visceral leishmaniasis
Number of cases of cutaneous leishmaniasis reported
Number of cases of visceral leishmaniasis reported
Action Plan for implementation of alcohol policy
Advertising restrictions on social media
Restrictions on product placement in films/movies
Importance of measures for enhancing compliance with age limits
Penalties for drink driving
Sobriety checkpoints
Price measures
New types of alcoholic beverages emerging
Level of taxation adjusted for inflation
Consumer information about calories, additives, etc on containers
Number of standard alcoholic drinks displayed on containers
Alcohol content displayed on containers
Government support for community action
Community-based interventions involving stakeholders
National guidelines for implementing effective community-based interventions
National alcohol policy specifically involves young people activities
Detection of marketing infringements
Penalties for marketing infringements
Antenatal care attendees positive for syphilis who received treatment (%)
Existence of standards
Year country was certified
Dracunculiasis cases
Ambient air pollution in urban areas (Annual PM<sub>2.5</sub> [&#956;g/m<sup>3</sup>])
Joint effects of air pollution attributable deaths
Joint effects of air pollution attributable deaths in children under 5 years
Joint effects of air pollution attributable deaths per 100'000 capita
Joint effects of air pollution attributable deaths per 100'000 children under 5 years
General government expenditure on health as percentage of gross domestic product
Out-of-Pocket expenditure on health as percentage of total health expenditure??
Prepaid plans as percentage of total health expenditure?
Legislation
Coordination
Surveillance
Response
Preparedness
Risk communication
Human resources
Laboratory
Points of entry
Zoonosis
Food safety
Chemical
Radionuclear
Children aged < 5 years with pneumonia symptoms taken to a health facility (%)
Demand for family planning satisfied - use of modern and traditional methods (%)
Full immunization coverage among one-year-olds (%)
Children aged < 5 years sleeping under insecticide-treated nets (%)
Pregnant women sleeping under insecticide-treated nets (%)
Measles immunization coverage among one-year-olds (%)
Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%)
Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%)
Births by caesarean section (in the two or three years preceding the survey) (%)
Postnatal care visit within two days of birth (in the x years preceding the survey) (%)
Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%)
Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)
Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI
Alcohol-attributable Years of Life Lost (YLL) score
Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)
Alcohol-attributable fractions (15+), road traffic crash deaths (%)
Alcohol-attributable fractions, all-cause deaths (%)
Alcohol, regional prevalence of alcohol dependence (%)
Alcohol, regional prevalence of alcohol use disorders (%)
Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Alcohol, average daily intake in grams among drinkers with 95%CI
Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016
Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI
Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI
15-19 years old heavy episodic drinkers (population), % with 95%CI
15-19 years old heavy episodic drinkers (drinkers only), %
15-19 years old abstainers, lifetime (%)
15-19 years old former drinkers (%)
15-19 years old, current drinkers (%)
Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis
Reported number of individuals treated for onchocerciasis
Status of endemicity of onchocerciasis
Deaths total
Deaths, children aged under 5 years
Disability-adjusted life years (DALYs) total (000s)
Disability-adjusted life years (DALYs), children aged under 5 years (000s)
Deaths per 100 000 population
Disability-adjusted life years (DALYs) per 100 000 population
Out-of-pocket expenditure as a percentage of total expenditure on health
Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach
Existence of at least one operational multisectoral national policy, strategy or action plan that integrates several noncommunicable diseases and shared risk factors in conformity with the global/regional noncommunicable disease action plans 2013?2020
Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets
Existence of population-based cancer registry
Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs
National guidelines for the prevention and reduction of alcohol-related harm in schools
National guidelines for alcohol problem prevention and counselling at workplaces
Workplace representatives nationally involved to prevent and address alcohol-related harm
Server training
Legal obligation for schools to include alcohol use prevention
Legal obligation for schools to interact with parents regarding education and well-being
Legislation on alcohol testing at workplaces
Standard drink defined
National systems for monitoring alcohol consumption and harms
Regular reports from national monitoring systems
Comprehensive and regular reporting of alcohol situation
Clinical guidelines for brief interventions
National surveys on adult alcohol consumption
National surveys on youth alcohol consumption
National surveys on heavy espisodic drinking
Data collection on Foetal Alcohol Syndome
Data collected on harm from alcohol at workplace
New types of alcoholic beverages emerging
Cases started on MDR-TB treatment
New or unknown treatment history cases: Pulmonary, clinically diagnosed
New or unknown treatment history cases: Pulmonary, bacteriologically confirmed
New cases: Pulmonary, smear-negative/unknown/not done and other new cases
Previously treated cases, excluding relapse
Relapse cases: Pulmonary, clinically diagnosed
Relapse cases: extrapulmonary
Relapse cases: Pulmonary, bacteriologically confirmed
Confirmed cases of RR-/MDR-TB
Treatment success rate: new TB cases
Treatment success rate: HIV-positive TB cases
Treatment success rate: XDR-TB cases
TB_new_snuoth
Status of bejel endemicity
Number of cases of bejel reported
Status of pinta endemicity
Number of cases of pinta reported
15-19 years old total alcohol consumption in litres of pure alcohol
Child maltreatment: Extent of implementation of home-visiting programmes
Youth violence: Extent of implementation of life-skills and social development programmes
Intimate partner violence: Extent of implementation of dating violence prevention programmes
Elder abuse: Extent of implementation of caregiver-support programmes
Extent of implementation of mental health services for victims of all types of violence
Extent of implementation of child protection services
Extent of implementation of medico-legal services for victims of sexual violence
Lifetime prevalence of child physical abuse (%)
Lifetime prevalence of child emotional abuse (%)
Lifetime prevalence of child sexual abuse (%)
Lifetime prevalence of child physical neglect (%)
Estimates of number of homicides
Estimates of rates of homicides per 100 000 population
Estimated antiretroviral therapy coverage among people living with HIV (%)
Estimated leptospirosis deaths (per 100 000 population)
Estimated leptospirosis incidence (per 100 000 population)
Composite coverage index (%)
Children aged < 5 years with diarrhoea receiving oral rehydration salts (%)
Overweight prevalence in children aged <three years (%)
Overweight prevalence in children aged < 5 years (%)
Wasting prevalence in children aged < 3 years (%)
Wasting prevalence in children aged < 5 years (%)
Prevalence of insufficient physical activity among school going adolescents aged 11-17 (crude estimate)
Number of imported cases of cutaneous leishmaniasis reported
Number of imported cases of visceral leishmaniasis reported
Total density per 100 000 population: Hospitals
Number of insecticide classes to which resistance was reported
Pyrethroid resistance reported for at least one site
Organochlorine resistance reported for at least one site
Carbamate resistance reported for at least one site
Organophosphate resistance reported for at least one site
Percentage of sites for which pyrethroid resistance was reported
Percentage of sites for which organochlorine resistance was reported
Percentage of sites for which carbamate resistance was reported
Percentage of sites for which organophosphate resistance was reported
Level of enforcement of BAC limits
Household air pollution attributable DALYs
General availability of urine testing for albumin
General availability of bronchodilators in the public health sector
Prevalence of anaemia in women of reproductive age (%)
Biomedical engineers density (per 10 000 population)
Average daily intake in grams of alcohol among drinkers
15-years old any alcoholic beverage consumed at least once in lifetime, (%)
15-years old any alcoholic beverage consumed in past 12 months, (%)
15-years old first drink at 13 years or younger, (%)
15-years old any alcoholic beverage consumed in past 30 days, (%)
15-years old, any alcoholic beverage consumed at least once a week, (%)
15-years old ever got drunk in the past 30 days, (%)
13-15-years old any alcoholic beverage consumed in past 30 days, (%)
13-15-years old first drink before age 14, (%)
Congenital syphilis number of reported cases
Congenital syphilis rate per 100 000 live births
Mental hospital admissions (per 100 000 population)
Outpatient visits (per 100 000 population)
Total workforce in mental health sector (per 100 000 population)
Occupational therapists in mental health sector (per 100 000 population)
Other non-specialized doctors in mental health sector (per 100 000 population)
Mental health units in general hospitals admissions (per 100 000 population)
Stand-alone policy or plan for mental health
Alcohol-related road traffic crashes with fatalities, per 100,000 population
Physical fighting, past 12 months (%)
Bullied, past 30 days (%)
Law mandates that health warnings appear on other smoked tobacco packages
Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
Specific health warnings are mandated for other smoked tobacco packaging
Number of health warnings approved by the law for other smoked tobacco packaging
Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health
Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging
Health warnings on other smoked tobacco packaging must be rotated
Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
Health warnings on other smoked tobacco packaging must include a photograph or graphic
Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Health warnings on other smoked tobacco packaging law requires or establishes fines for violations
Ban on deceitful terms on other smoked tobacco packaging
Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Other smoked tobacco packaging and labelling must not use descriptors depicting flavours
Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Other smoked tobacco packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of other smoked tobacco packaging
Display of expiry dates is prevented on other smoked tobacco packaging
The quit line number must appear on other smoked tobacco packaging or labelling
Law requires fines for violations of direct advertising bans
Law requires fines for violations of indirect advertising bans
Ban on internet sales of tobacco products
Ban on display of tobacco products at points of sale
Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place
Premium brand of cigarettes - currency reported
Premium brand of cigarettes - price in currency reported
Premium brand of cigarettes - price in international dollars
Premium brand of cigarettes - price in US$ at official exchange rates
Type of excise tax applied.
Uniform excise tax applied Yes (Uniform), No (Tiered/varying rates)
Greater reliance on specific tax in mixed excise regime
Minimum specific tax applied in ad valorem or mixed excise regime
Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
Affordability: Cigarettes are less affordable in 2014 compared to 2008
Specific tax component automatically adjusted for inflation (or other)
Tax administration: Tax stamps applied on tobacco products
Tax administration: Bans or limits on duty free imports by travellers
Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)
Compliance of ban on smoking in HEALTH-CARE FACILITIES
Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
Compliance of ban on smoking in UNIVERSITIES
Compliance of ban on smoking in GOVERNMENT FACILITIES
Compliance of ban on smoking in INDOOR OFFICES
Compliance of ban on smoking in RESTAURANTS
Compliance of ban on smoking in PUBS AND BARS
Compliance of ban on smoking in PUBLIC TRANSPORT
Compliance of ban on advertising on national TV and radio
Compliance of ban on advertising on local magazines and newspapers
Compliance of ban on advertising on billboards and outdoor advertising
Compliance of ban on advertising at point of sale
Compliance of ban on free distribution of tobacco products in the mail or through other means
Compliance of ban on promotional discounts
Compliance of ban on non-tobacco goods AND services identified with tobacco brand names
Compliance of ban on brand name of non-tobacco products used for tobacco product
Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)
Compliance of ban on appearance of tobacco products in TV and/or films
Compliance of ban on sponsored events
Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Tax structure: Excise tax proportion of price
Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand
Price dispersion: Share of cheapest brand price in premium brand price (%) (the higher the % the smaller the gap)
Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Number of maternal deaths
Law requires helmet to be fastened
Existence of national regulation
Year of national implementation of regulation
Vehicle standards
Access restrictions
Restriction and inspection of facilities
Information requirements
Training requirements
Safety requirements
Number of licensed qualified surgeons actively working
Number of licensed qualified obstetricians actively working
Number of licensed qualified anaesthesiologists actively working
Years of healthy life lost to disability (YLDs) due to leptospirosis
Years of healthy life lost to disability (YLDs) (per 100 000 population) due to leptospirosis
Years of life lost (YLLs) due to leptospirosis
Years of life lost (YLLs) (per 100 000 population) due to leptospirosis
Disability-adjusted life years (DALYs) due to leptospirosis
Disability-adjusted life years (DALYs) (per 100 000 population) due to leptospirosis
Adolescent birth rate (births per 1,000 women aged 15 to 19)
Households with at least one ITN for sleeping (%)
Children under five who slept under a bednet the previous night (%)
Children under five who slept under an ITN the previous night (%)
Contraceptive prevalence rate among women married or in union
Households with soap and water at a handwashing facility (%)
People who identify the use of condoms as a way to avoid AIDS (%)
Households with dirt floor (%)
Population not using any sanitation facility (open defecation) (%)
IPT 3rd dose
Prevalence of overweight and obesity
Ambient and household air pollution attributable death rate (per 100 000 population)
New HIV infections (per 1000 uninfected population)
Malaria incidence (per 1 000 population at risk)
Concentrations of fine particulate matter (PM2.5)
Mortality rate attributed to unintentional poisoning (per 100 000 population)
Proportion of population with primary reliance on clean fuels and technologies (%)
Age-standardized road traffic mortality (per 100 000 population)
Prevalence of current tobacco use among persons aged 15 years and older (age-standardized rate)
Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)
Reported number of people requiring interventions against NTDs
Out-of-pocket expenditure as a percentage of total expenditure on health
Proportion of births attended by skilled health personnel (%)
Married or in-union women of reproductive age who have their need for family planning satisfied with modern methods (%)
Adolescent birth rate (births per 1 000 women aged 15-19)
Literacy rate among adults aged >= 15 years (%)
Estimated direct deaths from major conflicts (per 100 000 population)
Average death rate due to natural disasters (per 100 000 population)
Crude suicide rates (per 100 000 population)
Skilled health professionals density (per 10 000 population)
Average of 13 International Health Regulations core capacity scores, 1st version of the questionnaire
Healthy life expectancy (HALE) at age 60 (years)
Number of people operated for trachomatous trichiasis
Existence of a national multisectoral commission, agency or mechanism for NCDs
Existence of a set of national NCD indicators and has set time-bound national targets for these indicators
Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors
Existence of any policies on marketing of foods to children
Existence of any policies to reduce population salt consumption
Existence of national policies on saturated fatty acids
Implementation of diet and/or physical activity public awareness program
General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level
General availability of diabetes testing (by HbA1c) at the primary health care level
Existence of a diabetes registry
Has a STEPS survey or a comprehensive health examination survey every 5 years
Existence of national screening program for breast cancer
Existence of national screening program for cervical cancer
Most widely used screening method in national cervical cancer screening program
Type of national cervical cancer screening program
Coverage of national cervical cancer screening program (%)
Existence of national HPV vaccination programme
General availability of retinal photocoagulation in the public health system
General availability of dialysis in the public health system
General availability of renal replacement by transplantation in the public health system
General availability of coronary bypass or stenting in the public health system
General availability of thrombolytic therapy in the public health system
General availability of palliative care in primary health care in the public health system
General availability of palliative care in community or home-based care in the public health system
Availability of cardiovascular risk stratification in 50% or more primary health care facilities
Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities
Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities
General availability of beta blockers in the public health sector
General availability of sulphonylurea(s) in the public health sector
Ambient air pollution attributable deaths
Ambient air pollution attributable death rate (per 100 000 population, age-standardized)
Ambient air pollution attributable DALYs
DALYs attributable to ambient air pollution (age-standardized)
Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)
Ambient air pollution attributable YLLs
YLLs attributable to ambient air pollution (age-standardized)
Ambient air pollution attributable deaths (per 100 000 population, age-standardized)
Estimated MDR/RR-TB cases among notified pulmonary TB cases
Decayed, missing, or filled teeth
Cataract surgical coverage of adults aged 50 and over (%)
Effective cataract surgical coverage of adults aged 50 and over (%)
Population in malaria-endemic areas who slept under an insecticide-treated bed net (ITN) the previous night (%)
Completeness of cause-of-death data (%)
National universal health coverage strategy
strategy refers to the use of ICT to support UHC
National eHealth strategy
National eHealth strategy refers to objectives of UHC
National health information system (HIS) policy or strategy
Public funding for eHealth
Private funding for eHealth
Donor/ non-public development funding for eHealth
Public-private partnerships for eHealth
Strategy implementation funding available for eHealth
Proportion of public funding
Proportion of private funding
Proportion of donor/non public development funding
Proportion ofpublic private partnerships funding
Government-supported health internet sites provide information in multiple languages
Tertiary institutions provide students of health sciences with training on eHealth
Institutions offer in-service training to health professionals on ICT for health
mHealth programmes are sponsored by government
Regulating mobile devices and software
Promoting standards and interoperability
Providing guidance on privacy and security
Providing oversight and enforcement of data ownership
Promoting the development and adoption of mHealth
Regulatory oversight of mobile apps for quality, safety and reliability
Providing incentives and guidance for innovation research and evaluation of health
Government-sponsored mHealth programmes are being evaluated
Capacity
Infrastructure
Funding
Effectiveness
Cost-effectiveness
Demand
Legal
Policy
Priorities
Country has telehealth policy or strategy
Strategy includes objectives as to how telehealth contributes to UHC
Evaluation of any government-sponsored telehealth programmes
eLearning is used in pre-service education to teach health sciences students
Reducing cost of delivering content
Improving access to content and experts
Enabling access to education where learning facilities are limited
Pre-service eLearning programmes have been evaluated
eLearning used for in-service training of health professionals
Reducing cost of delivering content
Improving access to content and experts
Enabling access to education where learning facilities are limited
eLearning courses accredited by continuing medical education or professional licensing bodies
eLearning programmes for in-service training of health professionals have been evaluated
Lack of capacity
Lack of infrastructure
Lack of funding
Not possible to gain a health sciences degree entirely through eLearning
Lack of evidence that eLearning is effective
Lack of evidence over cost-effectiveness
Lack of demand for eLearning programmes
Lack of suitable courses available
Insitutional educational policy does not include eLearning as an approach to teaching health sciences
Competing educational priorities
Country has national EHR
Country has specific legislation governing the use of national EHR system
Lack of capacity
Lack of infrastructure
Lack of funding
lack of evidence showing effectiveness of EHR
Lack of evidence showing cost-effectiveness or EHR
Lack of demand by health professionals and patients
Lack of legislation or regulations covering use of EHR
National strategy does not promote the adoption of EHR
Lack of national or international standards for interoperability of EHR
Competing health system priorities
to define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth
to address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria
to protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format
to protect the privacy of individuals' health-related data held in electronic format as an EHR
which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR
which governs the sharing of digital data between health professionals in health services in other countries through the use of an EHR
which allows for the sharing of personal and health data between research entities
which allows individuals electronic access to their own health-related data when held in an EHR
which allows individuals to demand that their own data be corrected when held in an EHR if it is known to be inaccurate
which allows individuals to demand the deletion of health-related data from their EHR
Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
Country has national policy or strategy on the use of social media by government organizations
Policy or strategy makes specific reference tothe use of social media in the health domain
Country has national policy or strategy regulating the use of big data in the health sector
Country has national policy or strategy regulating the use of big data by private companies
Effective standards and best practices for data capture not fully established
Insufficient incentives for data sharing
Capacity building required for new skills
Privacy and security laws need to be in place
Research into new analytical methods needs occur to meet the challenges of working with big data
Lack of integration between various health services
Prevalence of wasted children under 5 years of age (% weight-for-height <-2 SD)
Prevalence of overweight children under 5 years of age (% weight-for-height >+2 SD)
Prevalence of stunted children under 5 years of age (% height-for-age <-2 SD)
Prevalence of underweight children under 5 years of age (% weight-for-age <-2 SD) (%)
Households with at least one insecticide-treated mosquito net (ITN) and/or indoor residual spraying (IRS) in the past 12 months (%)
Existence of subnational regulation
Government unit/official responsible for prevention for substance use
Ministry/office that takes primary responsibility for prevention for substance use
Five years change in international cooperation for prevention for substance use
Government unit/official responsible for treatment of substance use disorders
Ministry/office that takes primary responsibility for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
Five years change in international cooperation for treatment of substance use disorders
Confidentiality of people in treatment for substance use disorders
Voluntary treatment for people with alcohol use disorders in the criminal justice system
Voluntary treatment for people with drug use disorders in the criminal justice system
Compulsory treatment for people with alcohol use disorders in the criminal justice system
Compulsory treatment for people with drug use disorders in the criminal justice system
Five-year change in government resources for prevention for substance use
Five-year change in government resources for treatment of substance use disorders
Financing methods for treatment for alcohol use disorders
Financing methods for treatment for drug use disorders
Hypothecated taxes to be spent on prevention and treatment for substance use disorders
Government benefits for people with alcohol use disorders
Government benefits for people with drug use disorders
Main sector for treatment for alcohol use disorders
Main sector for treatment for drug use disorders
Treatment programmes for children and adolescents with alcohol use disorders
Treatment programmes for children and adolescents with drug use disorders
Specialized treatment facilities for substance use disorders
Specialized treatment facilities for alcohol use disorders
Specialized treatment facilities for drug use disorders
Self-help groups
Main substance at treatment entry
Reported treatment coverage for substance dependence
Guidelines on pharmacological treatment for substance use disorders
Pharmacotherapy with methadone
Pharmacotherapy with buprenorphine
Pharmacotherapy with buprenorphine/naloxone
Access restrictions to maintenance treatment
Timeframe for maintenance treatment of opioid dependence
Registration of medications for alcohol dependence and withdrawal
Registration of medications for opioid dependence
Registration of medications for opioid withdrawal
Registration of naloxone for injection for opioid overdose
Availability of naloxone
Screening and brief intervention for substance use in primary health care
Screening and brief intervention for substance use in antenatal services
Recommendations for screening and brief interventions for substance use in primary health care
Recommendations for screening and brief interventions for substance use in antenatal services
Groups and agencies involved in prevention programs
Prevention programmes for alcohol
Prevention programmes for specific populations for alcohol
Prevention programmes for drugs
Prevention programmes for specific populations for drugs
HIV, Hepatitis counselling and treatment availability in specialized facilities and services
Programmes readily available
Standards of treatment and care for public specialized treatment facilities
Special treatment programmes for gambling disorder
Treatment programmes for women with alcohol use disorders
Treatment programmes for women with drug use disorders
Special housing services for alcohol use disorders
Special housing services for drug use disorders
Employment services for alcohol use disorders
Employment services for drug use disorders
Open access interventions for alcohol
Open access interventions for drugs
Health professionals providing treatment for alcohol and drug use disorders
Standards of care for professionals providing treatment for alcohol and drug use disorders
Educational attainment in prevention
Postgraduate training programme in prevention
Continuing professional development in prevention
Educational attainment in treatment
Postgraduate training programme in treatment
Continuing professional development in treatment
Epidemiological data collection for substance use
Service delivery data collection for substance use
Regular reports on epidemiological and service delivery data for substance use
System of monitoring alcohol involvement in forensic pathology
System of monitoring drugs involvement in forensic pathology
Epidemiological data collection system for substance use among children and adolescents
Epidemiological data collection system for substance use among children and adolescents
Treatment programmes for children and adolescents with alcohol use disorders
Treatment programmes for children and adolescents with drug use disorders
Ambient air pollution attributable DALYs (per 100 000 population, age-standardized)
Household air pollution attributable death rate (per 100 000 population)
Household air pollution attributable death rate (per 100 000 population, age-standardized)
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)
Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images
Ban on sponsorship (contributions and/or publicity of contributions)
Ban on any form of contribution (financial or other support) to any event, activity or individual
Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals
Ban on Corporate Social Responsibility activities (CSR)
Total environment attributable deaths in children under 5 years
Total environment attributable DALYs in children under 5 years
Population using safely managed drinking-water services (%)
Population using at least basic drinking-water services (%)
Population using safely managed sanitation services (%)
Population using at least basic sanitation services (%)
Population with basic handwashing facilities at home (%)
Prevalence of anaemia in children under 5 years (%)
Prevalence of anaemia in non-pregnant women (%)
Prevalence of anaemia in pregnant women (%)
Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
Prevalence of underweight among adults, BMI < 18.5 (age-standardized estimate) (%)
Prevalence of underweight among adults, BMI < 18.5 (crude estimate) (%)
Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (age-standardized estimate) (%)
Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)
Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)
Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (age-standardized estimate) (%)
Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%)
Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)
Data availability for UHC index of service coverage (ranking)
UHC index of service coverage (SCI)
Index of Service Coverage (Actual)
Data availability for UHC index of service coverage
Population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (%)
Population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (%)
Population pushed below the $1.90 a day poverty line by household health expenditures (%)
Population pushed below the $3.20 a day poverty line by household health expenditures (%)
Changes in poverty gap due to health expenditures at the $1.90 a day poverty line
Changes in poverty gap due to health expenditures at the $3.20 a day poverty line
Tuberculosis detection and treatment
Prevalence of non-elevated blood pressure (%)
Mean fasting plasma glucose
Surgeons (per 100 000)
Prevalence of non-use of tobacco
Compliance with international health regulations
Population practising open defecation (%)
Tuberculosis effective treatment coverage (%)
xxx
Availability of estimates on large health expenditures as a share of total expenditure or income
Availability of estimates on impoverishment due to out-of-pocket health expenditures
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a day poverty line (%)
Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a day poverty line (%)
Increase in poverty gap due to household health expenditures at the $3.20 a day poverty line, in cents of international dollars
Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (%)
Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (millions)
Total population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (%)
Total population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (millions)
Total population pushed below the $1.90 a day poverty line by household health expenditures (%)
Total population pushed below the $1.90 a day poverty line by household health expenditures (millions)
Total population pushed below the $3.20 a day poverty line by household health expenditures (%)
Total population pushed below the $3.20 a day poverty line by household health expenditures (millions)
Functioning national AMR surveillance plan
Establishment of National Coordination Centre (NCC)
Nomination of National Focal Point (NFP)
Establishment of national reference laboratory (NRL)
Number of surveillance sites reporting to GLASS: Hospitals
Number of surveillance sites reporting to GLASS: Outpatient facilities
Number of local clinical laboratories supporting national AMR surveillance sites
External Quality Assessment (EQA) provided to the national reference laboratory (NRL)
External Quality Assessment (EQA) provided for bacterial identification and Antimicrobial Susceptibility Testing (AST)
External Quality Assessment (EQA) provided to local laboratories participating in GLASS
GLASS pathogens testing covered by External Quality Assessment (EQA)
Types of Antimicrobial Susceptibility Testing (AST) standards followed by countries
Composite coverage index (%)
Demand for family planning satisfied - modern methods (%)
New HIV infections among adults 15-24 years old (per 1000 uninfected population)
Official development assistance for medical research and basic health sectors as a percentage of GNI (%), by donor country
Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country
Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)
Number of deaths attributed to non-communicable diseases, by type of disease and sex
Number of suicide deaths
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)
Prevalence of severely wasted children under 5 years of age (% weight-for-height <-3 SD)
Household and ambient air pollution attributable DALYs ('000)
Household and ambient air pollution attributable DALYs (per 100 000 capita)
Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized)
Household and ambient air pollution attributable DALYs in children under 5 years ('000)
Existence of a set of time-bound national targets based on WHO guidance
Implementation of physical activity public awareness program
Existence of operational policy/strategy/action plan for oral health
Existence of a register of patients who had rheumatic fever and rheumatic heart disease
Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease
Number of incident tuberculosis cases in children aged 0 - 14
Daily tobacco smoking, crude adjusted
Daily cigarette smoking, crude adjusted
Current tobacco smoking, crude adjusted
Current cigarette smoking, crude adjusted
Household air pollution attributable DALYs (per 100 000, age-standardized)
Ban on appearance of tobacco products in TV and/or films
Law requires fines for violations of indirect advertising bans
Subnational laws or regulations exist banning some or all types of tobacco advertising, promotion and sponsorship
Ban on internet sales of tobacco products
Ban on product display at point of sale
Law requires fines for violations of direct advertising bans
Water, sanitation and hygiene - population attributable fractions
Number of diarrhoea deaths from inadequate water, sanitation and hygiene
Number of diarrhoea deaths from inadequate water
Attributable fraction of diarrhoea to inadequate water
Number of diarrhoea DALYs from inadequate water
Diarrhoea deaths from inadequate water in children under 5 years
Diarrhoea DALYs from inadequate water in children under 5 years
Number of diarrhoea deaths from inadequate sanitation
Attributable fraction of diarrhoea to inadequate sanitation
Number of diarrhoea DALYs from inadequate sanitation
Diarrhoea deaths from inadequate sanitation in children under 5 years
Diarrhoea DALYs from inadequate sanitation in children under 5 years
Number of diarrhoea deaths from inadequate hygiene
Attributable fraction of diarrhoea to inadequate hygiene
Number of diarrhoea DALYs from inadequate hygiene
Diarrhoea deaths from inadequate hygiene in children under 5 years
Diarrhoea DALYs from inadequate hygiene in children under 5 years
Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene
Number of diarrhoea DALYs from inadequate water, sanitation and hygiene
Diarrhoea deaths from inadequate water, sanitation and hygiene in children under 5 years
Diarrhoea DALYs from inadequate water, sanitation and hygiene in children under 5 years
National legislation to prevent illegal alcohol sales
Cancer, age-standardized death rates (15+), per 100,000 population
Alcohol-attributable fractions (15+), cancer deaths
Heavy episodic drinking (youth 15 -19 years) past 30 days (%)
Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)
Regional prevalence, AAFs (15+), liver cirrhosis deaths (%)
Regional prevalence, AAFs (15+), road traffic crash deaths (%)
Regional prevalence, AAFs (15+), cancer
Regional prevalence, AAFs ,all-cause deaths (%)
Existence of tax on sugar-sweetened beverages
Number of biomedical engineers
Biomedical technicians density (per 10 000 population)
Number of biomedical technicians
Alcohol, consumption of pure alcohol by type of beverage (%)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)
Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)
Alcohol, abstainers lifetime (%)
Alcohol, abstainers past 12 months (%)
Alcohol, consumers past 12 months (%)
Alcohol, former drinkers (%)
Alcohol, heavy episodic drinking (population) past 30 days (%)
Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
Liver cirrhosis, age-standardized death rates (15+), per 100,000 population
Road traffic injuries, age-standardized death rates (15+), per 100,000 population
Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
Alcohol use disorders (15+), 12 month prevalence (%) with 95%
Cautions and arrests for drink-driving, per 100,000 population
Alcohol-related road traffic crashes, per 100,000 population
Alcohol-related road traffic crashes (% of all traffic crashes)
Alcoholic excise tax revenue as a per cent of government revenue
Annual revenues from alcohol excise tax in millions US$
Alcohol expenditure as a per cent of total household expenditure
Social costs of alcohol use in millions US$
Adopted written national policy on alcohol
Alcoholic beverage legally defined
Alcohol use is banned
National legislation to prevent illegal alcohol
Advertising restrictions on national television
Advertising restrictions on cable television
Advertising restrictions on national radio
Advertising restrictions on local radio
Advertising restrictions in print media
Advertising restrictions at cinemas
Advertising restrictions on billboards
Advertising restrictions at point-of-sale
Advertising restrictions on the internet
Restrictions on product placement on national television
Restrictions on product placement on cable television
Age limits on-premise service
Legal blood alcohol concentration (BAC) limits
Random breath testing (RBT) use
Restrictions on sales promotion from producers (parties, events)
Restrictions on sales promotion from retailers (sales below cost)
Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
Government monopoly on production
Government monopoly on retail sales
Licence required for production
Licence required for retail sales
Excise duty (average) per hectolitre in Euros
Duty paid or excise stamp on alcohol container
Excise tax on alcoholic beverages
Value-added tax (VAT) on alcohol (%)
Restrictions on alcohol use in public places
Health warning labels on alcohol advertising
Health warning labels on alcohol containers
Awareness activities
Standard drink measures, in grams per unit
Total (recorded+unrecorded) alcohol per capita (15+) consumption
Central coordinating entity for alcohol policy implementation
Framework of national alcohol policy
Level of adoption of national alcohol policy
Sectors represented in national alcohol policy
Cautions and arrests for public drunkenness, per 100,000 population
Adopted written national policy on alcohol, year adopted
Adopted written national policy on alcohol, year revised
Age limits off-premise sales
Action Plan for implementation of alcohol policy
Advertising restrictions on social media
Restrictions on product placement in films/movies
Penalties for drink driving
Sobriety checkpoints
Price measures
Level of taxation adjusted for inflation
Consumer information about calories, additives, etc on containers
Number of standard alcoholic drinks displayed on containers
Alcohol content displayed on containers
Government support for community action
Detection of marketing infringements
Penalties for marketing infringements
Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI
Alcohol-attributable Years of Life Lost (YLL) score
Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)
Alcohol-attributable fractions (15+), road traffic crash deaths (%)
Alcohol-attributable fractions, all-cause deaths (%)
Alcohol, regional prevalence of alcohol dependence (%)
Alcohol, regional prevalence of alcohol use disorders (%)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI
Alcohol, average daily intake in grams among drinkers with 95%CI
Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016
Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI
Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI
15-19 years old heavy episodic drinkers (population), % with 95%CI
15-19 years old heavy episodic drinkers (drinkers only), %
15-19 years old abstainers, lifetime (%)
15-19 years old former drinkers (%)
15-19 years old, current drinkers (%)
National guidelines for the prevention and reduction of alcohol-related harm in schools
National guidelines for alcohol problem prevention and counselling at workplaces
Server training
Legislation on alcohol testing at workplaces
Standard drink defined
National systems for monitoring alcohol consumption and harms
National surveys on adult alcohol consumption
National surveys on youth alcohol consumption
15-19 years old total alcohol consumption in litres of pure alcohol
Level of enforcement of BAC limits
15-years old any alcoholic beverage consumed in past 12 months, (%)
15-years old first drink at 13 years or younger, (%)
15-years old any alcoholic beverage consumed in past 30 days, (%)
15-years old, any alcoholic beverage consumed at least once a week, (%)
13-15-years old any alcoholic beverage consumed in past 30 days, (%)
13-15-years old first drink before age 14, (%)
National legislation to prevent illegal alcohol sales
Heavy episodic drinking (youth 15 -19 years) past 30 days (%)
Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)
Regional prevalence, AAFs (15+), liver cirrhosis deaths (%)
Regional prevalence, AAFs (15+), road traffic crash deaths (%)
Regional prevalence, AAFs (15+), cancer
Regional prevalence, AAFs ,all-cause deaths (%)
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Consumption by type of alcoholic beverage - market share (%)
Alcohol, tourist consumption (in litres of pure alcohol)
Abstainers (15-19 years), lifetime (%)
Abstainers (15-19 years), past 12 months (%)
Alcohol, patterns of drinking score
Age-standardized DALYs, alcohol use disorders, per 100,000
Age-standardized DALYs, breast cancer, per 100,000
Age-standardized DALYs, colon and rectum cancers, per 100,000
Age-standardized DALYs, diabetes mellitus, per 100,000
Age-standardized DALYs, drownings, per 100,000
Age-standardized DALYs, falls, per 100,000
Age-standardized DALYs, fires, per 100,000
Age-standardized DALYs, ischaemic heart disease, per 100,000
Age-standardized DALYs, liver cancer, per 100,000
Age-standardized DALYs, liver cirrhosis, per 100,000
Age-standardized DALYs, maternal conditions, per 100,000
Age-standardized DALYs, mouth and oropharynx cancer, per 100,000
Age-standardized DALYs, oesophagus cancer, per 100,000
Age-standardized DALYs, poisoning, per 100,000
Age-standardized DALYs, prematurity and low birth rate, per 100,000
Age-standardized DALYs, road traffic accidents, per 100,000
Age-standardized DALYs, self-inflicted injury, per 100,000
Age-standardized DALYs, other unintentional injuries, per 100,000
Age-standardized DALYs, violence, per 100,000
Age-standardized death rates, alcohol use disorders, per 100,000
Age-standardized death rates, breast cancer, per 100,000
Age-standardized death rates, colon and rectum cancers, per 100,000
Age-standardized death rates, diabetes mellitus, per 100,000
Age-standardized death rates, drownings, per 100,000
Age-standardized death rates, falls, per 100,000
Age-standardized death rates, fires, per 100,000
Age-standardized death rates, ischaemic heart disease, per 100,000
Age-standardized death rates, liver cancer, per 100,000
Age-standardized death rates, liver cirrhosis, per 100,000
Age-standardized death rates, maternal conditions, per 100,000
Age-standardized death rates, mouth and oropharynx cancer, per 100,000
Age-standardized death rates, oesophagus cancer, per 100,000
Age-standardized death rates, poisoning, per 100,000
Age-standardized death rates, prematurity and low birth rate, per 100,000
Age-standardized death rates, road traffic accidents, per 100,000
Age-standardized death rates, self-inflicted injury, per 100,000
Age-standardized death rates, other unintentional injuries, per 100,000
Age-standardized death rates, violence, per 100,000
Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000
Age-standardized death rates (15+ years), poisoning, per 100,000
Age-standardized death rates (15+ years), violence, per 100,000
Alcoholic psychosis, incidence, per 100,000
Hospital discharges, alcohol-related injuries and poisoning, per 100,000
Hospital discharges, alcoholic liver disease, per 100,000
Perceived trend in alcohol-related harm and consequences
Treatment admissions (inpatient), alcohol dependence, per 100,000
Treatment admissions (inpatient), alcoholic psychosis, per 100,000
Alcohol-related injury mortality, per 1,000
Alcohol-related disease mortality, per 100,000 (15+ years)
Surrogate alcohol consumption is a problem
Minimum legal drinking age
Mandatory driver education for habitual offenders
Prices for alcoholic beverages (average, US$)
Trend in real price of alcoholic beverages relative to CPI over the past five years
Off-premise sales restrictions on days
Off-premise sales restrictions on hours
Off-premise sales restrictions on places
Off-premise sales restrictions on outlet density
Off-premise sales restrictions at specific events
Off-premise sales restrictions at petrol stations
On-premise sales restrictions on days
On-premise sales restrictions on hours
On-premise sales restrictions on places
On-premise sales restrictions on outlet density
On-premise sales restrictions at specific events
On-premise sales restrictions to intoxicated persons
Restrictions on sponsorship of sporting events
Restrictions on sponsorship of youth events
Excise tax as a per cent of the retail price of alcoholic beverages
Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
Value-added tax (VAT), (%)
Monitoring
Treatment, services
Interventions, projects, training
Information, education, prevention
National drinking guidelines
Production in 1000s hectolitres
Imports in 1000s hectolitres
Sales of beer in 1000s hectolitres
Exports of beer (barley) in 1000s hectolitres
Perceived trend in production
Perceived trend in imports
Perceived trend in sales
Perceived trend in exports
Surveys, research
Counselling
Sales of wine in 1000s hectolitres
Sales of spirits in 1000s hectolitres
Exports of wine (grape) in 1000s hectolitres
Exports of spirits in 1000s hectolitres
Age-standardized DALYs, cerebrovascular disease, per 100,000
Age-standardized death rates, cerebrovascular disease, per 100,000
Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
Consumer information on alcohol and health at points of sale
Educational programmes involving target groups in school curriculum
Brief interventions as health promotion/disease prevention
Server training on a regular basis
Data collection on alcohol-related health indicators
System for monitoring alcohol-related harm
National treatment policy for alcohol use disorders
Persons with alcohol use disorders receiving treatment (%)
Designation of alcohol tax revenues to health services
National surveys on drink-driving
Public-funded alcohol research/monitoring programmes
Public funds designated for alcohol research/monitoring programmes, in Euros
Community-based interventions/projects involving stakeholders
Interventions/projects actively involving young people and civil society
Training in screening and brief interventions for alcohol problems
Counselling to children in families with alcohol problems
Counselling to pregnant women with alcohol problems
Prevention/counselling at workplaces for those with alcohol problems
Importance of measures for enhancing compliance with age limits
New types of alcoholic beverages emerging
Community-based interventions involving stakeholders
National guidelines for implementing effective community-based interventions
National alcohol policy specifically involves young people activities
Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)
Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Workplace representatives nationally involved to prevent and address alcohol-related harm
Legal obligation for schools to include alcohol use prevention
Legal obligation for schools to interact with parents regarding education and well-being
Regular reports from national monitoring systems
Comprehensive and regular reporting of alcohol situation
Clinical guidelines for brief interventions
National surveys on heavy espisodic drinking
Data collection on Foetal Alcohol Syndome
Data collected on harm from alcohol at workplace
New types of alcoholic beverages emerging
Average daily intake in grams of alcohol among drinkers
15-years old any alcoholic beverage consumed at least once in lifetime, (%)
15-years old ever got drunk in the past 30 days, (%)
Alcohol-related road traffic crashes with fatalities, per 100,000 population
Medical doctors (per 10 000 population)
Medical doctors (number)
Generalist medical practitioners (number)
Specialist medical practitioners (number)
Medical doctors not further defined (number)
Nursing and midwifery personnel (per 10 000 population)
Nursing and midwifery personnel (number)
Nursing personnel (number)
Midwifery personnel (number)
Dentists (per 10 000 population)
Dentists (number)
Dental Assistants and Therapists (number)
Dental Prosthetic Technicians (number)
Pharmacists (per 10 000 population)
Pharmacists (number)
Pharmaceutical Technicians and Assistants (number)
Environmental and Occupational Health and Hygiene Professionals (number)
Environmental and Occupational Health Inspectors and Associates (number)
Medical and Pathology Laboratory scientists (number)
Medical and Pathology Laboratory Technicians (number)
Physiotherapists (number)
Physiotherapy Technicians and Assistants (number)
Traditional and Complementary Medicine Professionals (number)
Community Health Workers (number)
New leprosy case detection rate per 1 000 000 population
Number of leprosy cases registered for treatment (prevalence)
Leprosy registered prevalence rate per 1 000 000 population
Number of new leprosy cases with G2D
Proportion of new leprosy cases with G2D
New leprosy cases with G2D rate per 1 000 000 population
Number of new leprosy cases among children (less than 15 years of age)
Number of new leprosy cases with G2D among children (less than 15 years of age)
Proportion of children (less than 15 years of age) among new leprosy cases
Number of new leprosy cases among females
Proportion of females among new leprosy cases
Status of endemicity of Taenia solium
Presence of porcine cysticercosis
Number of pigs in the country
Practice of backyard pig production
Inequality-adjusted Human Development Index
Population with access to improved sanitation
Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%)
Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
Average of 13 International Health Regulations core capacity scores, SPAR version
Year the law was enacted (latest revision)
Publication year of the policy or plan (latest revision)
Early initiation of breastfeeding (in the two years preceding the survey) (%)
Early initiation of breastfeeding (in the five years preceding the survey) (%)
Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%)
Contraceptive prevalence - use of modern methods (%)
Demand for family planning satisfied - use of modern methods (%)
Underweight prevalence in children aged < 3 years (%)
Underweight prevalence in children aged < 5 years (%)
BCG immunization coverage among one-year-olds (%)
DTP3 immunization coverage among one-year-olds (%)
Full immunization coverage among one-year-olds (%)
Measles immunization coverage among one-year-olds (%)
Polio immunization coverage among one-year-olds (%)
Low birth weight (in thousands)
Low birth weight, prevalence (%)
Total population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
Total population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (millions)
UHC SCI components: Reproductive, maternal, newborn and child health
UHC SCI components: Infectious diseases
UHC SCI components: Noncommunicable diseases
UHC SCI components: Service capacity and access
Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%)
Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities) by out-of-pocket payments (%)
Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)
Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)
Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)
Estimated number of MDR/RR-TB incident cases
Reporting countries
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Number of isolates tested for azithromycin
Number of isolates tested for cefixime
Number of isolates tested for ciprofloxacin
Number of isolates tested for ceftriaxone
Number of isolates tested for extended-spectrum cephalosporins
Reported number of tests performed where results were received by a person (testing volume)
Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population
Reported number of tests performed where results were received by a person (testing volume), reporting period
Medical doctors (%)
Nursing personnel (%)
General availability of Angiotensin II receptor blockers (ARBs) in the public health sector
General availability of bone marrow transplantation in the public health system
Existence of national policies on trans-fatty acid elimination
ICD-11 implementation progress level
Girls aged 15 years old that received the recommended doses of HPV vaccine (%)
Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis
Number of surveillance sites reporting to GLASS: In- and outpatient facilities
Total number of surveillance sites reporting to GLASS
No. of countries, territories and areas
No. of countries, territories and areas enrolled in GLASS (a)
No. of countries, territories and areas that reported information from the national surveillance system to GLASS
Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place
Cytisine - legally sold
Cytisine - place available
Cytisine - cost covered
Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Ban on advertising at point of sale
Ban on Corporate Social Responsibility activities (CSR)
Ban on tobacco companies/the tobacco industry publicizing their CSR activities
Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry
Law requires fines for violations of advertising bans
Law requires fines for violations of promotion and sponsorship bans
Subnational bans on tobacco advertising, promotion and sponsorship authority exists
Ban on tobacco vending machines
Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place
Process evaluation was employed to assess implementation of the campaign
Cheapest brand of cigarettes - price in currency reported
Cheapest brand of cigarettes - price in international dollars
Cheapest brand of cigarettes - price in US$ at official exchange rates
Tobacco excises have been increased in the last two years however due to price variability the effect is not necessarily apparent in the tax indicators.
A minimum price policy is implemented
Reported use of earmarked tobacco taxes
Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes
Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products
Ban on sale of duty-free or excise-free cigarettes
Affordability - category of change since 2008 (more affordable/less affordable/no change)
Overall compliance with bans on direct advertising (score)
Overall compliance with bans on promotion and sponsorship (score)
Compliance with ban on advertising on national television and radio (score)
Compliance with ban on advertising in local magazines and newspapers (score)
Compliance with ban on billboard and outdoor advertising (score)
Compliance with ban on advertising at point of sale (score)
Compliance with ban on free distribution in mail or through other means (score)
Compliance with ban on promotional discounts (score)
Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)
Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)
Compliance with ban on appearance of tobacco brands in TV and/or films (score)
Compliance with ban on appearance of tobacco products in TV and/or films (score)
Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)
Overall compliance with regulations on smoke-free environments (score)
Compliance with smoke-free health-care facilities law (score)
Compliance with smoke-free education facilities except universities law (score)
Compliance with smoke-free universities law (score)
Compliance with smoke-free government facilities law (score)
Compliance with smoke-free indoor offices law (score)
Compliance with smoke-free restaurants law (score)
Compliance with smoke-free pubs and bars law (score)
Compliance with smoke-free public transport law (score)
Year of most recent survey of adults
Representativeness of most recent survey of adults
Age range of most recent survey of adults
Title of most recent survey of adults
Name of latest adult prevalence survey (nonsmoked)
Year of latest adult prevalence survey (nonsmoked)
Representation of latest adult prevalence survey (nonsmoked)
Age range of latest adult prevalence survey (nonsmoked)
Year of most recent adolescent survey
Representativeness of most recent adolescent survey
Age range of most recent adolescent survey
Title of most recent adolescent survey
Name of latest youth prevalence survey (nonsmoked)
Year of latest youth prevalence survey (nonsmoked)
Representation of latest youth prevalence survey (nonsmoked)
Age range of latest youth prevalence survey (nonsmoked)
Prevalence of current tobacco use among adolescents (%)
Prevalence of daily tobacco use among adolescents (%)
Prevalence of current tobacco smoking among adolescents (%)
Prevalence of daily tobacco smoking among adolescents (%)
Prevalence of current cigarette smoking among adolescents (%)
Prevalence of daily cigarette smoking among adolescents (%)
Prevalence of current smokeless tobacco use among adolescents (%)
Prevalence of daily smokeless tobacco use among adolescents (%)
Prevalence of current e-cigarette use among adolescents (%)
Prevalence of daily e-cigarette use among adolescents (%)
Prevalence of current tobacco use among adults (%)
Prevalence of daily tobacco use among adults (%)
Prevalence of current tobacco smoking among adults (%)
Prevalence of daily tobacco smoking among adults (%)
Prevalence of current cigarette smoking among adults (%)
Prevalence of daily cigarette smoking among adults (%)
Prevalence of current smokeless tobacco use among adults (%)
Prevalence of daily smokeless tobacco use among adults (%)
Prevalence of current e-cigarette use among adults (%)
Prevalence of daily e-cigarette use among adults (%)
Estimate of current tobacco smoking prevalence (%)
Estimate of daily tobacco smoking prevalence (%)
Estimate of current tobacco use prevalence (%) (age-standardized rate)
Estimate of daily tobacco use prevalence (%) (age-standardized rate)
Estimate of current tobacco smoking prevalence (%) (age-standardized rate)
Estimate of daily tobacco smoking prevalence (%) (age-standardized rate)
Estimate of current cigarette smoking prevalence (%) (age-standardized rate)
Estimate of daily cigarette smoking prevalence (%) (age-standardized rate)
Institutional Births (birth taken place in a facility) (%)
Number of suspected yaws cases reported
Number of confirmed yaws cases reported
Severe wasting prevalence in children aged < 5 years (%)
New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population
Indicator 16.2.1: Proportion of children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month
Proportion of vaccination cards seen (%)
Number of reported cases of poliomyelitis by wild poliovirus (WPV)
NLIS: Early initiation of breastfeeding within 1 hour of birth (%)
Subclinical vitamin A deficiency in preschool-age children (serum/plasma retinol <0.70 μmol/L) (%)
Clinical vitamin A deficiency in women (history of night blindness during most recent pregnancy) (%)
Median urinary iodine concentration in children 6-12 years (μg/L)
Any antenatal iron supplementation (%)
Births in baby-friendly facilities (%)
Population below the international poverty line (%)
Nutrition Governance score
International Code on Marketing of Breast-milk Substitutes: Legal status of the Code
Maternity protection: Compliance with international labour standards
GDP per capita annual growth rate (%)
Prevalence of anaemia in children aged 6–59 months (%)
Number of children aged 6–59 months with anaemia (thousands)
Prevalence of anaemia in women of reproductive age (aged 15-49) (%)
Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)
Prevalence of anaemia in non-pregnant women (aged 15-49) (%)
Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)
Prevalence of anaemia in pregnant women (aged 15-49) (%)
Number of pregnant women (aged 15-49 years) with anaemia (thousands)
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime
Mean HDL cholesterol, age-standardized
Mean HDL cholesterol, crude
Mean total cholesterol, age-standardized
Mean total cholesterol, crude
Mean Non-HDL cholesterol, age-standardized
Mean Non-HDL cholesterol, crude
Status of endemicity of buruli ulcder
Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, age-standardized
Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, age-standardized
Prevalence of hypertension among adults aged 30-79 years, age-standardized
Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, age-standardized
Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, crude
Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, crude
Prevalence of hypertension among adults aged 30-79 years, crude
Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, crude
